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Abstract
Staphylococcus aureus must rapidly adapt to a variety of carbon and nitrogen sources
during invasion of a host. Within a staphylococcal abscess, preferred carbon sources
such as glucose are limiting, suggesting S. aureus survives through the catabolism of
secondary carbon sources. S. aureus encodes pathways to catabolize multiple amino
acids including those that generate pyruvate, 2-oxoglutarate, and oxaloacetate. To
assess amino acid catabolism, S. aureus JE2 and mutants were grown in complete
defined medium containing 18 amino acids but lacking glucose (CDM). A mutation in
glutamate dehydrogenase (gudB), which generates 2-oxoglutarate from glutamate,
abrogated growth in CDM suggesting that glutamate and those amino acids generating
glutamate, particularly proline, serve as the major carbon source in this media. Nuclear
Magnetic Resonance (NMR) studies confirmed this hypothesis. Furthermore, a mutation
in acetate kinase (ackA) also abrogated growth of JE2 in CDM suggesting that ATP
production from pyruvate-producing amino acids is also critical for growth. In addition,
although a functional respiratory chain was absolutely required for growth, the relative
oxygen consumption rate and intracellular ATP concentration were significantly lower
during growth in CDM when compared to growth in glucose-containing media. Finally,
transcriptional analyses demonstrated that genes coding for the enzymes that
synthesize glutamate from proline, arginine and histidine are repressed by CcpA and

v
carbon catabolite repression. We also demonstrated that in the absence of CcpA
repression, the global transcriptional regulator, CodY, functions to positively regulate
proline catabolism by activating putA expression. The arginine transcriptional regulator,
ArgR1, also functions to positively regulate putA expression, while the arginine
transcriptional regulators, ArgR2 and AhrC, are functioning to repress arginine
biosynthesis via argG; presumably in the presence of arginine. These data demonstrate
that pathways important for glutamate catabolism and ATP generation via Pta/AckA are
important for growth in niches where glucose is not abundant.
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Chapter 1
Amino Acid Metabolism in Bacillus subtilis and current knowledge in
Staphylococcus aureus

2

Introduction
Metabolism is central to microbial life, as all bacteria require carbon and
energy for growth and replication. While lifestyles and specific niches occupied
by organisms vary, the fundamental metabolic tasks are similar across divergent
species of bacteria. All organisms must regulate the uptake of nutrients and
coordinate energy, carbon, and nitrogen metabolism to sustain cell maintenance
and growth (1, 2).
Pathogenic bacteria such as Staphylococcus aureus transiently derive
their carbon and energy sources through destruction of host tissue via the
synthesis of a wide assortment of virulence factors (1). The specific carbon and
nitrogen sources available during host invasion are unclear as S. aureus has the
ability to establish an infection in a wide variety of niches within the human host,
including the heart, bone, kidney, blood, and soft tissue. Recent studies have
demonstrated that S. aureus adapts to the changing carbon sources and oxygen
availability found within specific organ systems.

For example, S. aureus

defective in anaerobic fermentation were less virulent than wild type in a mouse
model of kidney infection (3), while mutants defective in aerobic respiration were
unable to mediate infection in the heart or liver. However, kidney colonization
and subsequent abscess formation was unaffected in the mutants defective in
aerobic respiration (4).

Furthermore, mutants defective in CcpA, the global

carbon catabolite repressor, are less effective at infecting the liver where glucose
is abundant, but colonization in the kidney is not affected (5). Collectively, these
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data suggest that S. aureus uses distinct metabolic pathways to adapt to nutrient
availability and environmental changes within specific host niches.
S. aureus lacks the ability to utilize phospholipids, triglycerides, and
potentially other short chain fatty acids as carbon due to the lack of a β-oxidation
system and glyoxylate shunt pathway.

However, it has been presumed S.

aureus has the ability to utilize peptides/amino acids as carbon sources as it
encodes multiple oligopeptide permeases and free amino acid transporters, as
well as proteases that have the ability to degrade host proteins (6-9).
Bioinformatics analysis suggests that pathways are present to catabolize multiple
amino acids including those that generate the central metabolic intermediates
pyruvate, 2-oxoglutarate, and oxaloacetate (Table 1, Figure 1.1).

Taken

together, these data suggest S. aureus encounters environments within the host
where peptides and free amino acids may be abundant carbon sources, fueling
growth.
Recent work from Spahich and colleagues found that the addition of
lactate plus peptides support growth of S. aureus under moderate nitric oxide
(NO) stress (10).

These studies demonstrated that lactate quinone

oxidoreductase (Lqo) assimilates the lactate excreted during the fermentation of
glucose as a result of NO stress. Lqo generates pyruvate and subsequently
acetate via Pta/AckA in an NAD-independent manner and requires an electron
acceptor such as oxygen or nitrate (11).

Peptides are required under these

conditions to serve as a carbon backbone to facilitate gluconeogenesis,
suggesting a requirement for amino acid catabolism during pathogenesis.

4

Figure 1.1. Amino acid catabolic pathways in B. subtilis and S. aureus.
Genes in blue are encoded by B. subtilis. Genes in black are encoded by B.
subtilis and S. aureus. Genes in red are encoded by S. aureus.
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Table 1.1 Predicted amino acid catabolism in Staphylococcus
aureus FPR375

6

7

8

Amino acid catabolism
Bacteria take advantage of a wide range of nutrient sources available
within specific environments. The human body is a reservoir of nutrients for
pathogenic bacteria, which can be divided into numerous microenvironments.
Extracellular bacterial pathogens often face environments with frequently
changing nutrients; therefore, they must be able to scavenge those available
nutrient sources to fuel central metabolic pathways for generation of energy and
macromolecule production (12, 13).
Amino acids are essential building blocks for protein synthesis in all living
organisms. In many bacteria, the conversion of peptides to free amino acids and
the subsequent utilization of those amino acids in central metabolic pathways is
essential for growth and survival.

The hydrolysis of exogenous peptides via

peptidases allows for free amino acids to be utilized in processes such as protein
synthesis, generation of energy, and carbon metabolism (14).

Evidence

suggests that amino acid catabolism in anaerobic and fermentative bacteria is
important for obtaining energy in nutrient-limiting environments. For example, in
several species of lactic acid bacteria, arginine catabolized via the arginine
deiminase pathway (ADI) provides energy for growth via substrate-level
phosphorylation (15, 16). Furthermore, it has been known since the 1930’s that
in several nonpathogenic Clostridium species, amino acid metabolism via
Stickland fermentation is a primary source of energy when the bacteria are grown
with amino acids as sole sources of carbon and nitrogen (17-20).

Stickland

fermentation couples the oxidation of one amino acid (typically alanine, valine,
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leucine, serine, isoleucine, or threonine) to the reduction of another (typically
glycine, proline, or aspartic acid), resulting in organic acid production, redox
balance, and ATP synthesis via substrate-level phosphorylation (Figure 1.2; (21,
22). Recent work from Bouillaut and colleagues demonstrated that Stickland
fermentation of proline in the pathogenic Clostridium difficile is required for
optimal growth, even in rich media with abundant carbon sources (22). Taken
together, these data provide evidence of the importance of amino acid utilization
in central metabolism in several bacterial species.
To date little is known about S. aureus amino acid catabolism.

As

previously mentioned, bioinformatics analysis predicts S. aureus has the ability to
catabolize amino acids into three central metabolic intermediates (Table 1). The
glucogenic amino acids alanine, serine, glycine, threonine, and cysteine can
serve as precursors for the synthesis of pyruvate, while aspartate and
asparagine are substrates for the TCA cycle intermediate, oxaloacetate.
Furthermore, glutamate, glutamine, histidine, arginine, and proline can serve as
precursors for 2-oxoglutarate synthesis. Genes for complete catabolic pathways
were not identified for tryptophan, isoleucine, leucine, lysine, methionine,
phenylalanine, tyrosine, and valine.

The following sections will describe the

current knowledge of amino acid catabolic pathways in B. subtilis and how these
pathways may be involved in S. aureus amino acid catabolism. Figure 1.1 is an
overview of the pathways discussed in the following sections.
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Figure 1.2. Stickland Fermentation. Oxidation (A) and reduction (B) of pairs of
amino acids. The recycling of the electrons and protons facilitates redox balance
while generating ATP.
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2-oxoglutarate generating amino acids:
The TCA cycle intermediate, 2-oxoglutarate, is positioned at the
intersection of carbon and nitrogen metabolism.

It can be utilized in carbon

metabolism and energy generation via the TCA cycle, while also acting as the
major carbon skeleton for nitrogen-assimilatory reactions through its conversion
to glutamate via glutamate synthase (GOGAT). Intracellular 2-oxoglutarate may
serve as an indicator to the cell of the available carbon supply, as it has been
demonstrated that with the addition of glucose, there is a quick and significant
increase in intracellular 2-oxoglutarate (23). In B. subtilis, GOGAT expression is
induced in the presence of 2-oxoglutarate, while being suppressed by high
glutamate concentrations. Thus, the 2-oxoglutarate/glutamate ratio is regulating
nitrogen assimilation (24).

Glutamate and those amino acids that serve as

substrates for glutamate (proline, arginine, and histidine) can fuel 2-oxoglutarate
synthesis via the enzyme glutamate dehydrogenase in the absence of CcpA
repression (23, 25).
Glutamate.
Glutamate and glutamine serve as the major amino group donors for all
nitrogen-containing compounds, with glutamate providing 80-88% of the nitrogen
in nitrogenous compounds. In Escherichia coli, glutamate is the most abundant
metabolite in the cell, accounting for 40% of the metabolite concentration (26).
Glutamate is synthesized exclusively in B. subtilis from the carbon backbone of
2-oxoglutarate via glutamate synthase (GOGAT) and can also be degraded into
2-oxoglutarate directly via glutamate dehydrogenase, thus linking carbon and
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nitrogen

metabolism

(12,

27).

B.

subtilis

encodes

two

glutamate

dehydrogenases via the rocG and gudB genes. However, in most laboratory
strains of B. subtilis only RocG is enzymatically active (25, 28). GudB is inactive
due to a 9 bp direct repeat, causing a duplication of three amino acids in the
active center of the enzyme (29).

Interestingly, inactivation of rocG causes

spontaneous mutations to occur in GudB, resulting in enzymatic activity (28). In
S. aureus, only gudB is present and currently is not well characterized.
In B. subtilis, rocG is subject to regulatory signals from both carbon and
nitrogen metabolism. In the presence of glucose, CcpA strongly represses rocG
transcription through its interaction with the rocG promoter (28, 30). The rocG
gene is induced by the transcription factors AhrC and RocR in presence of
arginine, ornithine, and/or proline, allowing for the use of these compounds as
carbon and nitrogen sources (31-33). The alternative sigma factor, σL, is also
required for transcription of rocG. Interestingly, σL is also strongly repressed by
CcpA in the presence of glucose (34, 35). These layers of regulation, which are
dependent on the carbon and nitrogen sources available, ensure that an active
RocG is only present when the degradation of glutamate to 2-oxoglutarate is
required.
B. subtilis also utilizes glutamate as a substrate for both proline and
arginine synthesis. Proline can be synthesized via three enzymatic reactions
carried out by γ-glutamate kinase (ProB/ProJ), γ glutamyl-phosphate reductase
(ProA), and Δ1-pyrroline-5-carboxylate (P5C) reductase (ProI/ProH/ProG) (36).
However, S. aureus does not encode orthologus genes for this pathway and
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apparently cannot synthesize proline from glutamate. The absence of proline
synthesis via glutamate has been demonstrated by studies showing S. aureus
grown in the presence of radiolabeled glutamate does not result in the generation
of radiolabelled proline (37).
B. subtilis, among several other bacterial species, also utilizes glutamate
as a substrate for arginine synthesis via the highly conserved argJBCDFGH
operon. In this pathway, glutamate is catabolized in five enzymatic steps to
ornithine, which is then further catabolized into arginine via the urea cycle (38).
However, S. aureus is an arginine auxotroph despite the presence of all of the
arg genes within its chromosome (39, 40). While, transcription of argGH has
been detected by northern blot analysis in a ccpA mutant, argJBCDF transcript
has not been detected in any conditions tested. Furthermore, S. aureus grown in
the presence of

13

C-glutamate yields no accumulation of

13

C-arginine (41).

These data suggest three major differences in S. aureus glutamate catabolism
compared to B. subtilis. First, S. aureus only encodes gudB for catabolism of
glutamate into the TCA cycle intermediate, 2-oxoglutarate. Additionally, the S.
aureus genome does not encode orthologues to the B. subtilis proB/proJ, proA,
or proI/proH/proG genes involved in proline synthesis via glutamate degradation.
Lastly, S. aureus does not appear to utilize glutamate as a substrate for arginine
biosynthesis via the argJBCDFGH pathway.
Glutamine.
Glutamine is an optimal source of nitrogen for many bacteria.

In the

absence of glutamine, ammonium can be used as a source of nitrogen through
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assimilation with glutamate via glutamine synthetase (GS) and GOGAT. In this
cycle, GS (glnA) is expressed in the absence of glutamine and functions to
convert glutamate and ammonium into glutamine (42). GOGAT, encoded by
gltAB, produces two glutamate molecules from glutamine and 2-oxoglutarate via
reductive amination. In this reaction, glutamine provides an amide group to 2oxoglutarate, resulting in the synthesis of glutamate. GOGAT is only synthesized
in the presence of its substrates, 2-oxoglutarate and glutamine (12, 25, 27). S.
aureus encodes both GS and GOGAT genes, however, few studies have been
performed to elucidate how glutamate/glutamine metabolism functions in S.
aureus.
Proline.
In B. subtilis, proline can be utilized as a sole source of carbon or nitrogen
through its oxidation into glutamate via the putBCP operon (43).

Proline

dehydrogenase (PutB) catalyzes the conversion of proline into Δ1-pyrroline-5carboxylate (P5C), which is then spontaneously hydrolyzed to γ-glutamate-5semialdehyde. The NAD-dependent Δ1-pyrroline-5-carboxylate dehydrogenase
(PutC) then oxidizes γ-glutamate-5-semialdehyde further into glutamate.

The

high affinity proline transporter, PutP, is well suited for scavenging proline from
scarce nutritional environments (43-45). The expression of the putBCP operon is
dependent on the proline-responsive activator protein, PutR. PutR requires only
submillimolar concentrations of proline for induction of putBCP (43, 46). CodY, a
global

transcriptional

regulator

of

metabolic

genes,

represses

putBCP

transcription by displacing PutR (46). The presence of proline dehydrogenase
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(putA), Δ1-pyrroline-5-carboxylate dehydrogenase (rocA), and putP in the S.
aureus genome indicates the ability to transport and catabolize proline.
However, unlike B. subtilis, these genes are not found in an operon and there
does not appear to be an orthologus putR gene present within the genome.
In S. aureus, proline can also serve as a substrate for arginine
biosynthesis when grown on non-preferred carbon sources. It has been known
since the 1930’s that most strains of S. aureus exhibit multiple amino acid
auxotrophies when grown in media containing glucose, including arginine and
proline (39, 47). However, genomic analyses have shown that the S. aureus
genome contains genes necessary for the synthesis of all 20 amino acids (40). It
has been recently understood that some of these pathways, such as the
interconversion of proline and arginine, are repressed by CcpA and are only
induced when growing on non-preferred carbon sources (5, 37, 41). Nuxoll and
colleagues demonstrated that alleviation of CcpA repression mediates arginine
biosynthesis via proline degradation by proline dehydrogenase and the urea
cycle.

Moreover, S. aureus grown in the presence of

13

C-proline yields

accumulation of 13C-arginine (41).
Arginine.
Arginine catabolism has been extensively studied as many bacteria
contain more than one arginine catabolic pathway (38). B. subtilis can utilize
arginine as a sole nitrogen and carbon source through its conversion to
glutamate via the arginase pathway, generating two molecules of glutamate per
one molecule of arginine. The arginase pathway is encoded by two operons,
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rocABC and rocDEF, and converts arginine into glutamate in three enzymatic
steps. First, arginine is cleaved by arginase, encoded by rocF, into ornithine.
Ornithine

is

converted

aminotransferase (RocD).

to

γ-glutamate-5-semialdehyde

via

ornithine

In the last step of the arginase pathway, the

conversion of γ-glutamate-5-semialdehyde into glutamate is catalyzed by RocA.
While the protein encoded by rocB is of unknown function, rocC and rocE are
hypothesized to encode amino acid permeases (32, 38, 48). Induction of these
operons requires the positive transcriptional regulator RocR and the presence of
arginine, ornithine, citrulline, or proline. A second regulatory protein, AhrC, also
controls the expression of the arginase pathway. In the presence of arginine,
AhrC acts as a positive regulator of rocF and rocD transcription, while repressing
the arginine biosynthetic arg operon (48).

S. aureus encodes all the genes

necessary to convert arginine to glutamate via the arginase pathway.

As

previously mentioned, the S. aureus genome does not appear to encode an
orthologus rocR gene. However, it does encode an ahrC gene, though to date its
function in the regulation of arginine catabolism has not been demonstrated.
As previously discussed, S. aureus is an auxotroph for arginine and
proline. However, the interconversion of arginine and proline can be mediated
with the alleviation of CcpA repression. It has been demonstrated by Li et al. that
S. aureus can utilize arginine as a substrate for proline synthesis in the absence
of glucose via the Δ1-pyrroline-5-carboxylate reductase pathway, which utilizes
RocF and RocD, along with Δ1-pyrroline-5-carboxylate reductase (ProC).
Furthermore, it was demonstrated that when grown in the presence of

17

radiolabeled arginine, S. aureus accumulates radiolabeled proline, indicating
arginine is serving as a precursor to proline biosynthesis (5, 37).
Arginine can also be catabolized via the highly conserved arginine
deiminase (ADI) pathway.

ADI catalyzes the conversion of arginine into

ornithine, ammonia, and carbon dioxide, as well as the production of 1 mol of
ATP per 1 mol of arginine consumed.

ADI is comprised of three enzymes:

arginine deiminase (ArcA), ornithine carbamoyl transferase (ArcB) and
carbamate kinase (ArcC), which are encoded by the arc operon. The arc operon
also encodes an arginine/ornithine antiporter (ArcD) and two regulatory proteins,
ArgR and ArcR, which are dependent on arginine availability and anaerobic
conditions respectively (38, 49). Recently, increased attention has been drawn
to the ADI pathway in endemic S. aureus USA300 strains due to the acquisition
of a second copy of the arc operon found on the arginine catabolic mobile
element (ACME), which is hypothesized to contribute to the success of this
particular methicillin-resistant community associated S. aureus (CA-MRSA) strain
in colonizing acidic environments such as the skin (50, 51).
Transcription of the arc operon is subject to CcpA repression and is often
arginine dependent via the ArgR family of transcriptional regulators, ArgR and
AhrC (52-55). Expression of the arc operon is also induced under anaerobic
growth conditions and dependent upon ArcR, which is also encoded within the
arc operon (49).

In lactic acid bacteria it has been demonstrated that ADI

functions to mediate pH homeostasis and survival under low-pH stress via
ammonia synthesis (55, 56). In S. aureus USA300, it has been demonstrated
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that the acquisition of ACME has increased the pathogen’s ability to colonize the
skin, partially due to the contributions of ADI to pH homeostasis (51).
Furthermore, ammonia from ADI in Staphylococcus epidermidis contributes to
biofilm development, as well as pH homeostasis in the presence of organic acids
(57). The ATP generated via ADI also has the ability to provide S. aureus with
energy in nutrient limiting conditions, thus making ADI a critical component for
successful host colonization.
Arginine serves as a substrate for NO synthesis, a highly reactive free
radical gas, which is produced via the NO synthase enzymes (NOS). NOS is
well characterized in mammals and involved in a wide variety of cellular
processes, including protection against pathogens (58). A number of bacterial
NOS enzymes have also been identified in gram-positive species, including S.
aureus, with diverse functions in virulence, biofilm development, toxin synthesis,
and antibiotic resistance (59-61). Currently in S. aureus, there is evidence that
NOS contributes to hydrogen peroxide resistance and may be involved in
staphyloxanthin production (62).

Overall, arginine is involved in several

metabolic pathways important for survival within the host, including pH
homeostasis, energy production, and carbon and nitrogen metabolism, all
contributing to the virulence and success of the pathogen.
Histidine.
The histidine utilization (Hut) system is a widely distributed pathway
amongst bacteria in which histidine is degraded into glutamate. The first three
steps in this pathway appear to be universal, in which histidase (HutH) removes
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ammonia from histidine, yielding urocanate.

The hydration of urocanate to

imidazolone propionate (IP) is catalyzed by urocanase (HutU), followed by the
ring cleavage of IP by IP hydrolase (HutI) to yield formiminoglutamate (FIG).
Two pathways can utilize FIG; one generates glutamate in a two-step reaction
via FIG deiminase and formyl glutamate hydrolase (FGase) (63, 64). Another
pathway, found in B. subtilis, involves the hydrolysis of FIG to glutamate by FIG
hydrolase (HutG) (65).
Histidine synthesis requires an input of 20 high-energy phosphate bonds,
thus being one of the most expensive amino acids for the cell to synthesize (66).
Therefore, it is of no surprise that its degradation is stringently regulated. The
regulation of the hut pathway has been studied extensively in several bacteria
including Klebsiella pneumoniae, several Pseudomonas species, and B. subtilis.
The details of the regulatory mechanisms controlling histidine utilization differ
considerably among these bacteria; however, most species share several
common features including the following: (i) Exogenous hisitidine must be
present at higher concentrations than internal pools generated by histidine
synthesis for expression of hut genes.

(ii) Only if cells are limited in some

essential requirement that degradation of histidine can fulfill, such as a carbon
source, will the Hut enzymes be maximally expressed. (iii) The affinities of the
histidine degradative enzymes and the tRNA synthetases for histidine are such
that internal pools of histidine are not depleted below levels that would halt
protein synthesis (67).
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In B. subtilis, three proteins (HutP, CcpA, and CodY), acting at three
different sites within the operon, regulate hut transcription.

The hutP gene,

located just upstream of hutHUIG, encodes an antiterminator protein that binds to
a termination stem-loop structure located between hutP and the enzymeencoding genes of the operon in the presence of histidine, allowing for read
through of the termination signal (68, 69).

The hut operon is also strongly

repressed by availability of carbon sources via CcpA.

In the presence of

glucose, CcpA binds to catabolite responsive elements (cre) located within the
hut promoter and the hutP coding sequence, exerting repression of the hut
operon (70-72). Transcription of hut genes are also strongly repressed when
grown in the presence of amino acids by CodY binding to an operator site
(hutOA) just downstream from the hut promotor (69).

To date, there is little

knowledge of histidine utilization in S. aureus or the regulation thereof.
Oxaloacetate generating amino acids:
Oxaloacetate is a TCA cycle intermediate that provides a link between
gluconeogenesis/glycolysis, the TCA cycle, and amino acid metabolism.
Oxaloacetate can be utilized in several reactions that direct the carbon flux within
central metabolism to ensure efficient use of available carbon sources.

The

synthesis of citrate, which is catalyzed by citrate synthesis (GltA) via the
substrates oxaloacetate and acetyl-CoA, is essential for full TCA cycle activity
and generation of energy via respiration. However, in the absence of glycolytic
sugars oxaloacetate can fuel gluconeogenesis through phosphoenolpyruvate
carboxykinase (PckA) activity, which catalyzes the GTP-dependent formation of
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phosphenolpyruvate (PEP) from oxaloacetate (73-75). In B. subtilis, mutants
lacking PckA cannot grow on non-glycolytic carbon sources, as they are unable
to synthesize glycolytic intermediates necessary for growth and replication, such
as precursors for peptidoglycan synthesis (75).
Oxaloacetate occupies a key position in central metabolism in which it can
be utilized as a substrate in several different pathways depending on nutrient
availability. Therefore, it is of no surprise that multiple pathways also exist to fuel
its synthesis. Oxaloacetate, the beginning metabolite of gluconeogenesis, can
be synthesized from pyruvate via pyruvate carboxylase (Pyc), a reaction utilized
to replenish TCA cycle intermediates.

Pyc is constitutively expressed and

subject to strong allosteric activation by acetyl-CoA (75).

Asparagine and

aspartate are also able to fuel oxaloacetate synthesis via the hydrolysis of
asparagine to aspartate by the enzyme, asparaginase (AnsA). Aspartate can
then be converted to oxaloacetate by aspartate aminotransferase (AspB), which
catalyzes a transamination reaction via the conversion of aspartate and 2oxoglutarate to oxaloacetate and glutamate.

It is of importance to note that the

aspartate provides the carbon backbone for oxaloacetate in this reaction. This
reaction is also reversible, allowing for oxaloacetate to fuel aspartate and
asparagine synthesis if needed (76).

When carbon availability is scarce, B.

subtilis is able to fuel oxaloacetate synthesis and subsequent gluconeogenic
reactions via utilization of aspartate/asparagine, a process that is hypothesized to
be involved in sporulation (74, 75). S. aureus also has the ability to convert both
asparagine and aspartate to oxaloacetate via the asparaginase (AnsA) and
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aspartate aminotransferase (AspA) enzymes, however, the contribution of these
amino acids to central metabolism remains unknown.
Pyruvate generating amino acids:
Pyruvate is a versatile metabolic intermediate, generated from the
breakdown of glucose through glycolysis. Pyruvate can be utilized to generate
acetyl-CoA, which either enters the TCA cycle or is converted to acetate, both
pathways generating ATP (77). It can also be converted to acetoin during carbon
overflow metabolism to avoid over-production of potentially harmful weak-acids
(78). During anaerobic fermentation, pyruvate is converted to lactate for the
regeneration of NAD+ and redox balance. As previously discussed, pyruvate can
also be used as an acceptor of carbon dioxide to replenish oxaloacetate levels
and the TCA cycle via Pyc (75, 77).

The synthesis of several metabolites,

including amino acids, also require pyruvate as a precursor (76).
When carbon availability is limited, several amino acids can fuel pyruvate
synthesis. Both B. subtilis and S. aureus have the ability to directly convert
serine and alanine to pyruvate via serine dehydratase (SdaAB) and alanine
dehydrogenase (Ald), respectively.

Furthermore, threonine and glycine can be

converted to serine and subsequently pyruvate via SdaAB, while cysteine can be
converted to alanine and then pyruvate via Ald. While little is known about the
function of serine utilization in B. subtilis metabolism, it has been demonstrated
alanine can be utilized as a sole carbon or nitrogen source through its conversion
to pyruvate and ammonia via Ald. It has also been demonstrated that Ald is
necessary for normal sporulation in B. subtilis (79, 80). It is unclear, however,
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how these amino acids contribute to central metabolism in S. aureus when
carbon sources are limited.
The work described in this dissertation is designed to gain a better
understanding of the pathways involved in amino acid catabolism in S. aureus,
as utilization of these pathways may be critical during host colonization and
infection. Knowledge of these metabolic networks may help gain insight into
improved therapeutic strategies for the treatment of S. aureus infections.
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Chapter 2
Methods and Materials
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Bacterial strains and culture conditions.
The S. aureus strains used in this study are all derived from JE2, which is the
parent strain of the Nebraska Transposon Mutant Library (NTML) (81). Defined
bursa aurealis transposon mutants were obtained from the NTML (81). JE2 ccpA
and JE2 ackA have been previously described (41, 82, 83). S. aureus strains
were grown in either tryptic soy broth (TSB; Becton Dickinson, Franklin Lakes,
NJ), complete defined medium (CDM) as previously described (84) except no
glucose was added, or CDM with 0.25% glucose (CDMG). Cultures were grown
aerobically in a 1:10 volume to flask ratio, shaking at 250 rpm at 37°C. S. aureus
cultures were inoculated to 0.05 optical density at 600 nm (OD600) from overnight
cultures grown in either TSB, CDM or CDMG. Bacterial growth was assessed by
measuring the optical density at 600 nm. Anaerobic growth was measured in an
anaerobic chamber (Coy Laboratory Products, Inc., Grass Lakes, MI) using a
10:1 flask-to-volume ratio in CDM supplemented with 1.0 g/liter L-cysteine
hydrochloride (Sigma) with or without the addition of L-lactate (0.5%) and/or
sodium nitrate (20 mM). Growth was assessed in the anaerobic chamber with
shaking at 37°C at 250 rpm to ensure that the cells did not settle in the flask. For
time-kill curves, 100 µM of N,N′-dicyclohexylcarbodiimide (DCCD) in 95% ethanol
was added to cultures during early exponential growth (OD600=0.5 for CDM and
1.0 for TSB and CDMG).
Construction of JE2 ΔahrC mutant
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All primers (TABLE) used for construction and confirmation of the ahrC deletion
were generated based on the sequence of S. aureus USA300_FPR3757
(NC_007793.1). pNF293, the JE2 ΔahrC allelic replacement construct, was first
created by insertion of an 861-bp ahrC upstream PCR product (using primers
1999 and 2000; TABLE) into the EcoR1 and BAMH1 sites of pUC19 (85).
Second, a 755-bp ahrC downstream PCR product was amplified (using primers
2211 and 2212; TABLE) and ligated into the BamH1 and Pst1 sites of the pUC19
polylinker. The temperature-sensitive pE194 derivative pROJ6448 was ligated
into the PstI site of the plasmid (86). The completed construct, pNF293, was
electroporated into the RN4220 restriction-negative S. aureus strain (87).
Modified plasmid DNA was isolated using Wizard Plus MidiPrep kits (Promega,
Madison, WI) and transduced into S. aureus JE2 using phage 80α as previously
described (88). Allelic replacement was performed using previously described
methods (89). Genetic sequencing (Eurofins Genomics) using primers 2944 and
2945 confirmed in-frame deletion of ahrC in JE2 ΔahrC.
Construction of JE2 arcA1::kan arcA2::ΝΣ and JE2 rocF::tetL arcA1::kan
arcA2::ΝΣ mutants
The pKan plasmid (89) was transduced (88) into transposon mutant

JE2

arcA1::ΝΣ and allelic replacement was performed using previously described
methods (89) to construct JE2 arcA1::kan and confirmed by PCR and southern
blot analyses.

JE2 arcA1::kan was transduced (88) into JE2 arcA2::ΝΣ to

construct JE2 arcA1::kan arcA2::ΝΣ.

To construct JE2 rocF::tetL arcA1::kan

arcA2::ΝΣ mutants, pTet plasmid (89) was transduced (88) into the transposon
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mutant JE2 rocF::ΝΣ and allelic replacement was performed using previously
described methods (89) to construct JE2 rocF::tet. JE2 rocF::tet was transduced
(88) into JE2 arcA1::kan arcA2::ΝΣ to construct JE2 rocF::tet arcA1::kan
arcA2::ΝΣ.
Measurement of bacterial metabolites. Bacterial cultures were collected (1 ml
aliquots) and centrifuged at 14,000 rpm for 3 min.

The supernatants were

removed and stored at -80°C until use. Acetic acid, glucose, ammonia, and
and

L-lactic

D-

acid concentrations were determined using kits purchased from R-

Biopharm, according to manufacturer instructions.
Measurement of TCA cycle and respiration activity. For all assays, JE2 was
grown overnight aerobically in 25 ml of appropriate media. Cultures were
inoculated to an OD600 of 0.05 in TSB, CDM, or CDMG and were grown to early
exponential phase (OD600=0.5 for CDM and 1.0 for TSB and CDMG). These
data were analyzed using an unpaired t-test. A P value of ≤0.05 was considered
statistically significant.
ATP concentration: Intracellular ATP concentrations were determined using the
BacTiter-Glo kit (Promega) according to the manufacturer’s protocol and
normalized to total optical units.
NAD+/NADH concentration: Aliquots of bacterial cultures (24 ml) were harvested
by centrifugation at 4°C for 10 min at 4,000 rpm. Intracellular NAD+ and NADH
concentrations were determined using Fluoro NAD+/NADH kit (Cell Technology)
as previously described (82) and normalized to total cellular protein
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concentrations.
Oxygen consumption: Samples were collected and diluted in air-saturated TSB,
CDM, or CDMG to an OD600 of 0.3. Relative oxygen consumption rates were
determined for up to 120 min at 37°C by using a MitoXpress oxygen-sensitive
probe (Luxcel Biosciences) according to the manufacturer’s instructions and
normalized to total optical units.
Citrate concentrations: Aliquots of bacterial cultures (24 ml) were harvested by
centrifugation at 4°C for 10 min at 4,000 rpm. The bacterial pellets were washed
twice with 1 ml of phosphate-buffered saline, pH 7.4 (PBS) and subsequently
resuspended in 1 ml PBS. The cells were lysed using lysing matrix B tubes in a
FastPrep FP120 instrument (Qbiogene). The lysates were centrifuged for 3 min
at

14,000

rpm

and

deproteinized

using

perchloric

acid/KOH.

Citrate

concentrations in the lysates were determined by using a Citrate fluorometric
assay kit (BioVision) according to the manufactures protocol and normalized to
total cellular protein concentrations.
Amino acid analysis. JE2 was grown overnight in 50 ml (500 ml flask) of TSB or
CDMG.

Cultures were inoculated to an OD600 of 0.05 in TSB (from TSB

overnight), CDM, CDMG, and CDMP (all from CDMG overnight) and grown for
12 hours. 1 ml of media was collected every 4 hours and centrifuged for 3 min at
14,000 rpm. Supernatant was collected and filterd through 3,000 MWCO Amicon
Ultra centrifugal filters (Millipore) according to the manufacturer’s protocol.
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Amino acid analysis was performed by the Protein Structure Core Facility,
UNMC, using a Hitachi L-8800.
NMR sample preparation. Three independent 50-ml cultures of S. aureus JE2
were grown to exponential phase (4hr-6hr) and stationary phase (8hr-10hr) in
CDM, CDMG, and CDMP containing either
arginine,

13

C5-glucose, or

13

13

C5-glutamate,

C5-pyrutate (Sigma-Aldrich).

13

C5-proline,

13

C5-

Cultures were

normalized to an OD600 of 40 and pelleted by centrifugation (6000 rpm at 4°C for
5 min). Pelleted cells were subsequently washed two times with 10 ml of cold
sterile water and resuspended in 1 ml cold sterile water and transferred to a
lysing matrix B tube (MP Biomedicals). The cells were lysed using an FP120
FastPrep cell disrupter (MP Biomedicals) and centrifuged at 13,200 rpm for 15
min at 4°C. The pelleted debris was resuspended in 1 ml of cold sterile water
centrifuged again as above. Supernatants from the two centrifugation steps were
combined and stored at -80°C for NMR analysis.
NMR data collection and analysis. The collected supernatants were lyophilized
and reconstructed in NMR buffer (KH2PO4/K2HPO4 buffer in D2O, pH 7.4, with
500 uM TMSP as an internal standard). 2D 1H-13C HSQC spectra were
collected on a Bruker DRX Avance 500-MHz spectrometer equipped with a 5-mm
triple-resonance cryoprobe (1H, 13C, and 15N) with a z-axis gradient, a BACS120 sample changer, Bruker ICON-NMR, and an automatic tuning and matching
(ATM) unit. NMRPipe (28) and NMRViewJ (29) were used to process and
analyze collected spectra. After being referenced in chemical shift and
normalized in intensity to the internal standard TMSP, peaks were annotated by
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comparing their chemical shifts to the metabolite reference data from the
Platform for RIKEN Metabolomics (PRIMe, http://prime.psc.riken.jp/) (30), Human
Metabolome

Database

(HMDB,

http://www.hmdb.ca/)

Metabolomics

Consortium

Metabominer

(http://wishart.biology.ualberta.ca/metabominer/)

Database

(31),

Madison

(http://mmcd.nmrfam.wisc.edu/)
(33),

(32),
and

BiomagResBank (BMRB, http://www.bmrb.wisc.edu/) (34) with an error tolerance
of 0.08 ppm and 0.25 ppm for 1H and

13

C chemical shifts, respectively. The

intensity of each metabolite was calculated by averaging the intensities of peaks,
which were unambiguously assigned to the metabolite.
RNA isolation and northern blot analysis. Cultures of S. aureus JE2 and JE2
ccpA were grown overnight in TSB, CDM and CDMG and inoculated to an OD600
of 0.05 into TSB (TSB overnight), CDM, CDMG, respectively. Cultures were
grown at 37°C in a 1:10 volume to flask ratio at 250 rpm. 15 ml of bacterial
culture were collected at mid-exponential phase (3hr-6hr) and post-exponential
phase (7hr-10hr) of growth and centrifuged at 5,000 rpm for 10 min at 4°C. Cell
pellets were resuspended in RLT buffer with 1% β-mercaptoethanol and
transferred to lysing matrix B tubes (MP Biomedicals).

They were then

processed in an FP120 FastPrep cell disrupter (MP Biomedicals) for 24 s at a
setting of 6.0. Cells were then pelleted at 13,000 rpm for 15 min at 4°C. The
top-phase was combined with 500 µL of ethanol and the samples were then
processed using an RNeasy mini kit, according to manufacturer’s instructions
(Qiagen, Inc.) Primers listed in Table S2 were used to make DNA probes that
were subsequently labeled with digoxigenin-labeled dUTP (Roche). 1 µg of RNA
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was used for northern analysis that was performed using DIG buffers and
washes (Roche). Anti-Digoxigenin-AP Fab fragments (Roche) was used with
ECF substrate (GE Healthcare) for detection. Blots were visualized using the
Typhoon FLS 7000 imaging system (GE Healthcare).
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Table 2.1 Bacterial strains and plasmids used in this study
Bacterial Strain or
Plasmid

Relevant Phenotype

Source

pUC19

Gram-negative origin of replication, Ampr

Invitrogen

pE194 containing pC221 nick site
pROJ6448

functioning in conjugative mobilization,
temp sensitive gram-positive origin of

(86)

replication, Ermr

pNF293

E. coli DH5α

ahrC allelic replacement vector for
makerless, in-frame ahrC mutant; AmpR,
ErmR

Plasmid cloning host and Gramnegative replicon

This study

Invitrogen

S. aureus RN4220

Restriction deficient NCTC8325-4

(90)

S. aureus JE2

LAC cured of all 3 native plasmids

S. aureus JE2
ald::ΝΣ

bursa aurealis mutation in alanine
dehydrogenase

This study

S. aureus JE2
sdaAA::ΝΣ

bursa aurealis mutation in serine
dehydratase, alpha subunit

This study

(91)
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S. aureus JE2
aspA::ΝΣ

bursa aurealis mutation in aspartate
amino transferase

This study

S. aureus JE2
ansA::ΝΣ

bursa aurealis mutation in asparaginase

This study

S. aureus JE2
rocF::ΝΣ

bursa aurealis mutation in arginase

This study

S. aureus JE2
putA::ΝΣ

bursa aurealis mutation in proline
dehydrogenase

This study

S. aureus JE2
gudB::ΝΣ

bursa aurealis mutation in glutamate
dehydrogenase

This study

S. aureus JE2
hutU::ΝΣ

bursa aurealis mutation in urocanate
hydratase

This study

S. aureus JE2
sucA::ΝΣ

bursa aurealis mutation in 2-oxoglutarate
dehydrogenase, EI component

This study

S. aureus JE2
sucC::ΝΣ

bursa aurealis mutation in succinyl-CoA
synthetase, beta subunit

This study

S. aureus JE2
sdhA::ΝΣ

bursa aurealis mutation in succinate
dehydrogenase, flavoprotein subunit

This study

S. aureus JE2
fumC::ΝΣ

bursa aurealis mutation in fumerate
hydratase

This study

S. aureus JE2
mqo1::ΝΣ

bursa aurealis mutation in malate
quinone oxidoreductase

This study

S. aureus JE2
pckA::ΝΣ

bursa aurealis mutation in phosphoenol
pyruvate carboxykinase

This study

S. aureus JE2
ΔackA::ermB

Allelic exchange mutant in ackA; Ermr

(82)

34

S. aureus JE2
pyc::ΝΣ

bursa aurealis mutation in pyruvate
carboxylase

This study

S. aureus JE2
arcA1::kan
arcA2::ΝΣ

bursa aurealis mutations in arcA1 and
arcA2; TetR, ErmR, KanR

This study

S. aureus JE2
rocF::tet arcA1::kan
arcA2::ΝΣ

bursa aurealis mutations in rocF, arcA1,
and arcA2; ErmR, KanR

This study

S. aureus JE2
gltA::ΝΣ

bursa aurealis mutation in citrate
synthase

This study

S. aureus JE2
acnA::ΝΣ

bursa aurealis mutation in aconitase

This study

S. aureus JE2
icd::ΝΣ

bursa aurealis mutation in isocitrate
dehydrogenase

This study

S. aureus JE2
gltB::ΝΣ

bursa aurealis mutation in glutamate
synthase, large subunit

This study

S. aureus JE2
rocD::ΝΣ

bursa aurealis mutation in ornithine
amino transferase

This study

S. aureus JE2
rocA::ΝΣ

bursa aurealis mutation in Δ1-pyrroline-5carboxylate dehydrogenase

This study

S. aureus JE2
argR1::ΝΣ

bursa aurealis mutation in
SAUSA300_2571, arginine repressor

This study

S. aureus JE2
argR2::ΝΣ

bursa aurealis mutation in
SAUSA300_0066, arginine repressor

This study

S. aureus JE2
codY::ΝΣ

bursa aurealis mutation in
SAUSA300_1148

This study
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S. aureus JE2
ΔahrC

Markerless deletion in SAUS200_1469,
arginine repressor

This study

pKAN

pTnT with aphA-3

(89)

pTET

pTnT with tet(M)

(89)
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Table 2.2 Oligonucleotides used in this study

Name

Sequence (5’ to 3’)

Target

2838

GCTTCATCAACATGGCGTAA

Forward primer to
amplify putA

2839

ATGATGCGATGGTCATGTGT

Reverse primer to
amplify putA

2840

TTCCACCCAGATGTTGATGA

Forward primer to
amplify gudB

2841

GGCATTACCGAAACCTTGAA

Reverse primer to
amplify gudB

2932

GAAGCAGTTGGTGATGCAGC

Forward primer to
amplify rocA

2933

GCACGTGAACATGCTGAACA

Reverse primer to
amplify rocA

2034

ATTGATGCAGCACAAGCAAG

Forward primer to
amplify rocD

2035

CCGCTGTTAACCAAGGTCAT

Reverse primer to
amplify rocD

AGGTACCTGCTGTGAACATTGA

Forward primer to
amplify rocF

2836

2837

3100

GAACGCCATCAACATTGCGT

GGACAGATGACAGCCGGTAG

Reverse primer to
amplify rocF
Forward primer to
amplify hutU
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3101

AGCCTGGGAAGTCAAAAGCA

Reverse primer to
amplify hutU

1872

CAAAATCTATGGGGCAGAGC

Forward primer
used to amplify
argG

1873

CCATGCAACATCGCATTTAC

Reverse primer
used to amplify
argG

ACACAAACATGGGTTGCTCA

Forward primer
used to amplify
argJ

1881

GTTTCCCATTGTGGATGGTC

Reverse primer
used to amplify
argJ

1999

CCCGGGGAATTCTCGGCGGTCAAATGTTAGA
T

5’ Forward ahrC
contains EcoRI*
restriction site

2000

CCCGGGGGATCCCACAGTAAACACCTCTGAT
TACGAA

5’ Reverse ahrC
contains BamHI*
restriction site

2211

CCCGGGGGATCCTAAGGATGCGATGAGTTTA
TG

3’ Forward ahrC
contains BamHI*
restriction site

2212

CCCGGGCTGCAGCGATCAGTGATAGCATTTT
C

3’ Reverse ahrC
contains PstI*
restriction site

TCTTCAAACAATTGACGCTTATT

Forward ahrC
mutant
confirmation

CCTTCGATGACAGCCTTTT

Reverse ahrC
mutant
confirmation

1880

2944

2945

*Restriction site denoted in italics
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Chapter 3

Amino acid catabolism in Staphylococcus aureus
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Introduction
S. aureus has the ability to establish infections in a wide variety of metabolic
niches within the human host including, among others, the heart, bone, kidney, blood,
and soft tissue. Significant advances have been made in the study of bacterial virulence
factors and their functions in human disease and infection of these various organ
systems.

However, we have only begun to study how particular carbon and nitrogen

sources that are available to S. aureus in specific host niches affect virulence factor
expression and subsequent invasion, metastasis or quiescence. As these metabolic
pathways are required for bacterial proliferation within the host, knowledge of these
pathways may reveal novel avenues for drug development.
A critical component of the innate immune response is the synthesis of nitric
oxide (NO) by inducible nitric oxide synthase (iNOS) within activated phagocytes (92).
Nitric oxide has wide ranging effects on bacterial cells including the disruption of lipid
biosynthesis, central metabolism, respiration and DNA replication (93). Data from an
evolving model demonstrates that, in contrast to other staphylococcal species, S. aureus
has the ability to grow under NO stress by fermenting glucose via lactate dehydrogenase
generating lactate and facilitating NAD+ regeneration to maintain glycolytic flux and
redox balance (3, 10, 11, 94, 95). Under NO stress conditions, glycolysis is an essential
process as a mutation in the glycolytic enzyme pyruvate kinase (pyk) severely inhibits
initiation of abscess formation in a skin and soft tissue murine model (95). Indeed,
inhibitors of pyruvate kinase have proved promising against S. aureus and other grampositive pathogens (96-99).
Following invasion of host tissue, S. aureus replicates in abscess communities
that are encapsulated within fibrin deposits and infiltrating immune cells (100). Much

40
recent work has led to an overarching view of abscess formation including the definition
of essential virulence factors such as coagulase, Von Willebrand factor, ClfA, FnbpA,
and FnbpB (101). As the abscess matures within the fibrin wall, the center includes a
large cluster of viable cells called the staphylococcal abscess community (100, 102). It is
hypothesized that these niches have low concentrations of NO allowing for respiratory
activity (3, 103); however, it is predicted that S. aureus must grow on non-preferred
carbon sources as glucose is not abundant (10, 104). Indeed, S. aureus lacks the ability
to utilize phospholipids, triglycerides, and potentially other short chain fatty acids as
carbon sources due to the lack of both β-oxidation and glyoxylate shunt pathways.
Therefore, other carbon sources that are available include lactate, excreted from S.
aureus during fermentative growth, as well as peptides and free amino acids. Recent
work from Spahich and colleagues found that the addition of lactate plus peptides
supports growth of S. aureus under low NO stress (10). Growth under these conditions
was dependent upon lactate quinone oxidoreductase (lqo), which assimilates lactate in
an NAD-independent manner and requires an electron acceptor such as oxygen or
nitrate (11). Importantly, growth under these conditions also required peptides to serve
as a carbon source to facilitate gluconeogenesis.
To date, little is known about amino acid catabolism in S. aureus; however,
bioinformatics analysis suggests that pathways are present to catabolize multiple amino
acids including those that generate pyruvate, 2-oxoglutarate, and oxaloacetate (Table
1.1). Although it is unclear in which microniches amino acid/peptide catabolism is
important, it has been presumed that S. aureus utilizes peptides/amino acids as carbon
sources as it encodes multiple oligopeptide permeases and free amino acid transporters
(6-8). In addition, S. aureus encodes metallo, serine and papain-like cysteine proteases
that have the ability to degrade host proteins (9). We have recently demonstrated that at
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least some of these amino acid catabolic pathways, such as those linking arginine and
proline, are repressed by carbon catabolite repression (via CcpA) and are only induced
when S. aureus is growing on non-preferred carbon sources (5, 37, 41). Thus, a S.
aureus ccpA mutant interconverts arginine and proline via an intact urea cycle (5, 37,
41).
In this study, we utilized genetic and NMR metabolomics approaches to investigate
amino acid catabolism in S. aureus USA300 JE2. We found that glutamate catabolism
via GudB, which functions to replenish the TCA cycle via 2-oxoglutarate, is required for
growth in a glucose-free medium. In addition, ATP generated from the Pta/AckA
pathway is also required for growth, presumably due to a significantly reduced
respiration rate. These data provide a model suggesting that certain amino acid
catabolic pathways are essential for growth in niches where glucose is limiting.
Results
Growth of S. aureus in Complete Defined Medium lacking glucose (CDM).
Staphylococcal growth and central metabolism have been well studied in tryptic
soy broth (TSB), which contains 14 mM glucose and an ill-defined concentration of
peptides and free amino acids (1). Therefore, to fully assess amino acid catabolism, a
complete defined medium was prepared as described by Hussain and colleagues except
that no glucose was added (84). This medium contains 18 amino acids but excludes
glutamine and asparagine. Aerobic growth of JE2 in CDM reached an OD600 maximum
of 3.0 following 8 hours (Figure 3.1). 2.3 mM acetate was produced by 6 hours of growth
(Figure 3.1) indicating catabolism of the glucogenic amino acids yielding pyruvate and
the generation of acetate via Pta/AckA (82, 105). Acetate was subsequently consumed
from the medium as a secondary carbon source and presumably oxidized via the TCA
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cycle (Figure 3.1) (106). Amino acid analysis of the spent medium demonstrated that
alanine, serine, glycine, threonine, arginine, proline, glutamate, and aspartate were
rapidly consumed by 8 hours of growth, whereas histidine was not consumed until 12
hours of growth (Figure 3.2). Consistent with these data was the generation of ammonia,
which reached a maximum concentration of 4.3 mM at 6 hours of growth (Figure 3.1)
and is indicative of amino acid catabolism (57). There was a gradual consumption of
other amino acids (cysteine, lysine, phenylalanine, tyrosine, leucine, isoleucine, valine,
and methionine) indicating probable use for protein synthesis but not for catabolic
purposes (Figure 3.2). Based on bioinformatics analyses, S. aureus JE2 encodes genes
for enzymes that function to catabolize amino acids to the metabolic intermediates
pyruvate (from alanine, serine, glycine, threonine, and cysteine), 2-oxoglutarate (from
glutamate, glutamine, histidine, arginine, and proline), and oxaloacetate (from aspartate
and asparagine) (Table 1.1). Complete catabolic pathways could not be identified for
tryptophan, isoleucine, leucine, lysine, methionine, phenylalanine, tyrosine, and valine.
Outside of cysteine, which was not catabolized by JE2 in CDM, these analyses agreed
with our experimental observations as detailed in Figure 3.2. To determine which
catabolic pathways are required for growth in CDM, mutants from each predicted
pathway (Table 1.1: ald, alanine; sdaAA, serine, glycine, and threonine; aspA, aspartate;
ansA, asparagine; rocF, arginine; putA, proline; gudB, glutamate; and hutU, histidine)
were chosen from a sequence defined transposon library (81) and growth analysis was
performed (Figure 3.3 and Figure 3.4A-H). These data demonstrated that of these genes
mutated, only gudB (Figure 3.4G), which encodes glutamate dehydrogenase and
catalyzes the reaction between glutamate and 2-oxoglutarate, was required for growth in
CDM. In addition, a mutation within, hutU yielded a markedly increased lag phase
(Figure 3.4H) whereas a mutation in putA (Figure 3.4F) resulted in a growth yield defect.
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Figure 3.2. Amino acid consumption of JE2 following growth
in CDM. JE2 was grown aerobically in CDM and amino acid
concentrations (mM) were measured in the supernatant at 0, 4, 8
and 12 hours of growth.
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Figure 3.3. Amino acid catabolic pathways in S. aureus. Green arrows
indicate those mutations that result in no significant growth defect as compared
to wild type JE2 in CDM. Blue arrows indicate those mutations that result in
intermediate growth defects as compared to wild type JE2 in CDM. Red arrows
indicate mutations that completely inhibit growth of JE2 in CDM. Black arrows indicate
that these pathways were not tested. Please see Figure 3.4 for growth analyses.
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Figure 3.4. Growth of JE2 and transposon mutants in CDM. Aerobic growth (250
rpm, 1:10 volume to flask ratio, 37° C) of JE2 bursa aurealis mutants from the
Nebraska Transposon Mutant Library in CDM. Data represents means ± SEM of
three biological replicates.
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Figure 3.4. Growth of JE2 and transposon mutants in CDM. Aerobic growth (250
rpm, 1:10 volume to flask ratio, 37° C) of JE2 bursa aurealis mutants from the
Nebraska Transposon Mutant Library in CDM. Data represents means ± SEM of
three biological replicates.
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Collectively, these data suggest that carbon derived from glutamate and those amino
acids that can be converted to glutamate, particularly proline and histidine, serve as the
major carbon sources for fueling the TCA cycle and subsequent gluconeogenic reactions
via phosphoenolpyruvate carboxykinase (pckA) (Figure 3.3). Based on these
observations, we predicted that mutations in the TCA cycle enzymes generating
oxaloacetate from 2-oxoglutarate would also be required for growth. Therefore,
transposon mutants in sucA (2 oxoglutarate dehydrogenase), sucC (succinyl Co-A
synthetase), sdhA (succinate dehydrogenase), fumC (fumarase), and mqo1 (malate
dehydrogenase) were grown in CDM (Figure 3.4I-M). As predicted, no growth was
observed with the sucA, sdhA, and fumC mutants (Figure 3.3, Figure 3.4I-L). However,
growth, albeit delayed, was observed with the mqo1 mutant (Figure 3.3, Figure 3.4M).
This suggests that oxaloacetate can also be supplied by aspartate/glutamate
transamination via AspA. Indeed, an mqo1 mutant was unable to grow in CDM lacking
aspartate (CDM-D; Figure 3.5). Lastly, as predicted, no growth was observed for the
pckA mutant, which is a critical enzyme required for gluconeogenesis via the generation
of phosphoenolpyruvate from oxaloacetate (Figure 3.3, Figure 3.4N). The putA (proline),
rocF (arginine), hutU (histidine), and rocA (arginine and proline) transposon mutants
were grown in CDM lacking glutamate (CDM-E) to determine which amino acid
substrates that fuel glutamate synthesis are most crucial (Figure 3.6). As a result we
found that the putA and rocA mutants had significant growth yield defects whereas
mutations in rocF and hutU had only moderate growth defects compared to wildtype JE2
grown in CDM-E. Thus, these data show that proline, arginine and histidine all serve to
fuel glutamate synthesis when glutamate is limiting; however, proline via PutA and RocA
is the major source of glutamate.
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Figure 3.5. Growth of S. aureus JE2 in CDM-D. Growth of JE2 and JE2
mqo1::NΣ in CDM lacking aspartate (CDM-D). Data represents means ±
SEM of three biological replicates.

54

Figure 3.6. Growth of S. aureus JE2 in CDM-E. Growth of JE2
putA::NΣ, JE2 rocF::NΣ, JE2 rocA::NΣ, and JE2 hutU::NΣ in CDM lacking
glutamate (CDM-E) in comparison to wildtype JE2. Data represents
means ± SEM of three biological replicates.
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As shown in Figure 3.1, growth of JE2 in CDM produces acetate suggesting that
the glucogenic amino acids generating pyruvate (serine, threonine, glycine, and alanine)
are important for ATP synthesis via substrate-level phosphorylation in the Pta/AckA
pathway (82). To determine the importance of this pathway, JE2 ΔackA (82) was grown
in CDM and, as shown in Figure 3.4O and Figure 3.3, growth was significantly reduced
suggesting that generation of ATP via this pathway may be critical to growth using amino
acids as carbon sources. Lastly, we found only a minor growth defect with the pyc
mutant, suggesting that pyruvate flux is directed primarily towards acetate synthesis,
instead of oxaloacetate and the TCA cycle (Figure 3.4P and Figure 3.3).
NMR metabolomic analysis of amino acid catabolism in S. aureus.
The previously described experiments suggested that proline primarily serves to
fuel glutamate synthesis and thus may serve as the major carbon source to fuel
gluconeogenesis when glutamate is limiting. In addition, it is predicted that the
glucogenic amino acids serine, threonine, glycine and alanine are primarily catabolized
to acetate to fuel ATP synthesis. To address these hypotheses and to determine the fate
of carbon following amino acid catabolism,

13

C labeled glutamate, arginine, proline,

aspartate, histidine, serine, threonine, alanine, and glycine were individually added to
CDM and assayed via NMR metabolomics in mid- and post-exponential growth.
Glutamate, proline, and arginine
Metabolic intermediates originating from

13

C labeled glutamate, proline and

arginine were very similar and included gluconeogenic intermediates (glucose-6-P and
phosphoglycerate),

and

intermediates

that

function

in

nucleotide

biosynthesis

(dihydroorotate, ribose, uracil and adenosyl homocysteine) and glycolipid/lipoteichioic
acid synthesis (glucose 1-phosphate) (Figure 3.7 and Figure 3.8A-C) (107). In addition,
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both aspartate and asparagine were detected from all three

13

C labeled amino acids

suggesting these amino acids were synthesized from oxaloacetate and the TCA cycle. It
is important to note that glutamate was synthesized from both proline and arginine,
presumably via RocA (Figure 3.3, Figure 3.7, and Figure 3.8A-C). However, as
previously reported, proline and arginine were not produced from glutamate (41).
Importantly, these results suggest proline and arginine can both serve as carbon
sources as they both serve as precursors for glutamate, the key intermediate linking
carbon and nitrogen metabolism. However, the relative amount of glutamate generated
from proline was approximately five-fold greater than the amount generated from
arginine (Figure 3.7, Figure 3.8B and 3.8C). And, as previously noted, a mutation in rocF
had minimal effect on growth in CDM and CDM-E. It is important to note that JE2
contains two copies of arginine deiminase, which can generate citrulline and ornithine
from arginine while bypassing RocF (50, 57). However, an arcA1/arcA2 arginine
deiminase mutant also had no significant growth defect in CDM (Figure 3.4Q). Thus,
these NMR data are consistent with our genotypic growth analysis and show that proline
is rapidly catabolized to generate glutamate and facilitate subsequent gluconeogenic
reactions.
Previous work demonstrated that arginine is synthesized via proline and the urea
cycle in a ccpA mutant (41) but not through the well-defined glutamate to arginine
pathway as described in B. subtilis and other bacteria (38). Although genes for the arg
pathway are present in S. aureus, growth conditions where they are induced are not
known. In a similar manner, work from others (5, 37) demonstrated that arginine served
as a precursor for proline biosynthesis in a ccpA mutant via RocF, RocD, and ProC.
Electrophoretic mobility shift assay (EMSA) analysis demonstrated that CcpA bound to
the promoters of both rocF and rocD, but not proC (5).
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Figure 3.7. Summary of cellular metabolite concentration changes resulting
from uniformly labeled amino acids supplemented in CDM. Summary on
following page.
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Figure 3.7. Summary of cellular metabolite concentration changes resulting from
uniformly labeled amino acids supplemented in CDM. The bubble plot summarizes
the metabolites derived from [U-13C4] aspartate (D), [U-13C5] glutamate (E), [U-13C5]
proline (P), [U-13C6] histidine (H), [U-13C6] arginine (R), [U-13C4] threonine (T), [U-13C3]
serine (S), [U-13C3] alanine (A) or [U-13C2] glycine (G) based on an analysis of triplicate
2D 1H-13C HSQC experiments. Due to the wide dynamic range of NMR intensities, the
original NMR peak intensities were transformed by natural logarithm for the purpose of
visualization. The relative size of the bubble indicates the transformed value where a
larger diameter indicates a higher NMR peak intensity. The bubbles are colored using a
red color-gradient to represent the original NMR peak intensity, where an increase in red
color intensity represents a corresponding increase in the original NMR peak intensity.
Each level increase in red intensity corresponds to a tenfold increase in the NMR
intensity. The bubbles with a purple outline ( ) identify metabolites observed during
exponential phase. Bubbles with a green outline (

) identify metabolites observed

during stationary phase. Metabolite names are colored based on an assigned category:
urea cycle (orange), amino acid (green), glycolysis/gluconeogenesis (black), pentose
phosphate pathway/nucleosides (red), and others (blue).
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Figure 3.8 NMR Peak intensity of CDM supplemented with 13C labeled amino
acids. Metabolites derived from [U-13C5] glutamate (E) (A), [U-13C5] proline (P) (B),
[U-13C6] arginine (R) (C), [U-13C6] histidine (H) (D), [U-13C4] aspartate (D) (E), [U-13C3]
alanine (A) (F), [U-13C2] glycine (G) (G), [U-13C4] threonine (T) (H), [U-13C3] serine (S)
(I), based on an analysis of triplicate 2D 1H-13C HSQC experiments. Samples were
assayed in either early (OD600=0.8-1.0) or late exponential (OD600=2.0-2.2) phases of
growth.
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alanine (A) (F), [U-13C2] glycine (G) (G), [U-13C4] threonine (T) (H), [U-13C3] serine (S)
(I), based on an analysis of triplicate 2D 1H-13C HSQC experiments. Samples were
assayed in either early (OD600=0.8-1.0) or late exponential (OD600=2.0-2.2) phases of
growth.
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(I), based on an analysis of triplicate 2D 1H-13C HSQC experiments. Samples were
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Figure 3.8 NMR Peak intensity of CDM supplemented with 13C labeled amino
acids. Metabolites derived from [U-13C5] glutamate (E) (A), [U-13C5] proline (P) (B),
[U-13C6] arginine (R) (C), [U-13C6] histidine (H) (D), [U-13C4] aspartate (D) (E), [U-13C3]
alanine (A) (F), [U-13C2] glycine (G) (G), [U-13C4] threonine (T) (H), [U-13C3] serine (S)
(I), based on an analysis of triplicate 2D 1H-13C HSQC experiments. Samples were
assayed in either early (OD600=0.8-1.0) or late exponential (OD600=2.0-2.2) phases of
growth.
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Figure 3.8 NMR Peak intensity of CDM supplemented with 13C labeled amino
acids. Metabolites derived from [U-13C5] glutamate (E) (A), [U-13C5] proline (P) (B),
[U-13C6] arginine (R) (C), [U-13C6] histidine (H) (D), [U-13C4] aspartate (D) (E), [U-13C3]
alanine (A) (F), [U-13C2] glycine (G) (G), [U-13C4] threonine (T) (H), [U-13C3] serine (S)
(I), based on an analysis of triplicate 2D 1H-13C HSQC experiments. Samples were
assayed in either early (OD600=0.8-1.0) or late exponential (OD600=2.0-2.2) phases of
growth.
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Thus, when S. aureus is growing on non-preferred carbon sources, an intact urea cycle
is critical for the interconversion of arginine and proline. Since CDM does not contain a
preferred carbon source, it is predicted that CcpA-repression would be alleviated and
pathways to interconvert proline and arginine would be transcriptionally active. As
predicted, proline synthesis was detected when

13

C labeled arginine was added to CDM,

however, arginine synthesis was not detected from
Instead, ornithine was detected from

13

13

C labeled proline (Fig. 3.7).

C labeled proline suggesting, in addition to its use

in glutamate synthesis, carbon from proline also enters the urea cycle. To further
investigate arginine synthesis in CDM, JE2 and JE2 ccpA::tet were grown in media
lacking either proline (CDM-P) or arginine (CDM-R). It was found that JE2 ccpA::tetL
grew in both CDM-P and CDM-R, although growth was delayed in CDM-R (Fig 3.9). In
addition, as predicted, JE2 wildtype grew in CDM-P, but a rocF mutant could not,
suggesting that proline synthesis is fueled by arginine in CDM (Fig 3.9). However,
unexpectedly, but consistent with the NMR data, JE2 could not grow in CDM-R
suggesting that proline cannot serve as a precursor for arginine synthesis in the absence
of a ccpA mutation.
Histidine and aspartate
Carbon derived from

13

C histidine was primarily identified in glutamate

metabolism and cysteine biosynthesis intermediates (Figure 3.7 and Figure 3.8D).
Consistent with our amino acid analysis where histidine was catabolized more slowly
than glutamate, proline, and arginine (Figure 3.2), significantly more metabolites
(especially glutamate) were identified in the post-exponential phase as compared to the
exponential phase. This observation suggests histidine is catabolized after proline and
arginine are limited or depleted.
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Figure 3.9. Growth of S.aureus JE2 in CDM-P and CDM-R. Growth of JE2
rocF::NΣ, JE2 ccpA::tetL, and JE2 wildtype in CDM lacking proline (CDM-P) or
arginine (CDM-R) (D). Data represents means ± SEM of three biological replicates.
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As the carbon backbone of aspartate enters central metabolism via oxaloacetate, it is
not surprising that many metabolic intermediates derived from

13

C aspartate were

identified, including those that function in gluconeogenesis, the pentose phosphate
pathway, nucleotide biosynthesis, amino acid biosynthesis, and glutamate metabolism
(Figure 3.8E). Indeed, as noted in Figure 3.4C, an aspA mutant, which is unable to
synthesize oxaloacetate from aspartate, has an increased lag phase as compared to
wildtype.
Alanine, glycine, threonine, and serine
The metabolic intermediates derived from these

13

C glucogenic amino acids were

very similar, reflecting their direct catabolism to pyruvate (Figure 3.7 and Figure 3.8F-I).
Similar to other amino acids assayed, carbon derived from the glucogenic amino acids
was

identified

in

gluconeogenic

intermediates, other

amino

acids, nucleotide

biosynthesis, and glutamate. However, significantly more extracellular acetate was
derived from alanine, threonine and serine as compared to other amino acids (Figure
3.10A). Therefore, we hypothesized a bifurcation exists during amino acid catabolism
where pyruvate generated from the glucogenic amino acids is primarily utilized to
generate acetate and ATP via AckA and little carbon enters the TCA cycle via citrate
synthase until acetate is consumed from the medium at six hours of growth. In addition,
those amino acids that generate glutamate enter the TCA cycle at 2-oxoglutarate via
GudB and serve as a carbon source to subsequently facilitate gluconeogenesis (Figure
3.3). Although it is clear from the NMR data that the

13

C glucogenic amino acids

synthesize glutamate, this hypothesis predicts that mutations within gltA (citrate
synthase), acnA (aconitase), and icd (isocitrate dehydrogenase) would not abrogate
growth in contrast to mutations in other TCA cycle genes past the 2-oxoglutarate node.
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Figure 3.10. Extracellular acetate production via amino acid catabolism and
intracellular citrate concentrations as an indicator of TCA cycle activity. (A)
Extracellular acetate detected following aerobic growth in CDM containing [U-13C4]
aspartate (D), [U-13C5] glutamate (E), [U-13C5] proline (P), [U-13C6] histidine (H), [U13
C 6] arginine (R), [U-13C4] threonine (T), [U-13C3] serine (S), [U-13C3] alanine (A) or [U13
C 2] glycine (G). NMR peak intensity was assessed in early exponential (early), mid
exponential (middle) and late exponential (late) growth based on an analysis of
triplicate 2D 1H-13C HSQC experiments. (B) Intracellular concentration of citrate as
measured in early and post-exponential phases of growth in CDM (*p<.05).
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Indeed, transposon mutants within gltA, acnA, and icd were grown in CDM, and, in
contrast to the sucA, sdhA, and fumC TCA cycle mutants, growth was observed albeit
with growth rate and yield defects (Figure 3.4R-T and Figure 3.3). In agreement with this
premise, intracellular citrate concentrations, as an indicator of TCA cycle activity and
entry of carbon into the TCA cycle, increased 3-fold during post-exponential growth in
CDM as compared to exponential growth (Figure 3.10B). Collectively, since we detected
citrate in early exponential growth in CDM and we observed growth defects with the gltA,
icd, and acnA mutants even before acetate is depleted from the medium (6 hours of
growth; Figure 3.1), these data suggest that the TCA cycle is active throughout growth in
CDM, but carbon flux is reduced through the TCA cycle and is instead routed to acetate
when amino acids that generate pyruvate are present in the medium. Once these amino
acids are depleted (primarily serine, threonine and alanine), acetate is consumed and
enters the TCA cycle to generate 2-oxoglutarate.
Respiration is reduced, but required for viability, during growth of S. aureus in
CDM
As an ackA mutant was unable to grow in CDM, we hypothesized that the ATP
generated by acetate kinase is critical for growth under these conditions. We reasoned
that the two NADH generated by 2-oxoglutarate dehydrogenase (SucA) and malate
quinone oxidoreductase (Mqo1) are utilized during gluconeogenesis to regenerate NAD+
and maintain redox balance. Thus, the net NADH may be reduced during growth in CDM
below levels needed to drive oxidative phosphorylation from the staphylococcal
NADH:quinone oxidoreductase. Therefore, experiments were designed to determine if
respiration is reduced during growth in CDM as compared to TSB or CDM containing 14
mM glucose (CDMG). The relative rate of oxygen consumption during growth in CDM
was approximately 50% of the rate in TSB; and the rate was significantly lower than that
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detected in CDMG (Figure 3.11A). Consistent with these observations, the relative
intracellular ATP concentration during growth in CDM was 12% of the concentration in
TSB (Figure 3.11B). Collectively, these data suggest that growth in CDM yields
significantly decreased respiratory activity and coincident ATP synthesis.
S. aureus contains a branched respiratory chain and has at least two terminal
menaquinol oxidases, QoxABCD (cytochrome aa3 oxidase) (4, 108) and CydAB
(cytochrome bd oxidase) (109). To date, the presence of a third terminal oxidase, a
cytochrome bo oxidase, is unclear (110). Respiratory complexes that feed the
menaquinone pool include succinate dehydrogenase (Sdh) (111), lactate quinone
oxidoreductase (Lqo) (10, 11, 112), and malate quinone oxidoreductase (Mqo) (10, 11).
Furthermore, S. aureus does not contain a complex I NADH oxidoreductase, but instead
encodes a type 2 non-electrogenic NADH:quinone oxidoreductase (Ndh2) that may be
linked to an NuoL-like protein MpsA that functions to translocate cations, but has no
NADH binding capability (113). The lack of growth demonstrated by a succinate
dehydrogenase mutant (Figure 3.3 and Figure 3.4K) and the decreased ATP
concentration and oxygen consumption noted during growth in CDM led us to address
the importance of the electron transport chain during growth in CDM. Transposon
mutants deficient in NADH:quinone oxidoreductase (nrd; SAUSA300_0844), and quinol
oxidase (qox) were cultured in CDM, however, both the nrd and qox mutants were
unable to grow aerobically in CDM (Figure 3.12A). Furthermore, growth of S. aureus was
halted in CDM
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Figure 3.11. Metabolic indicators of JE2 growth in CDM, TSB or CDMG. Relative
rate of oxygen consumption (A) and ATP concentration (B) following growth of JE2 in
CDM, CDMG or TSB. Rates of JE2 grown in TSB were set at 100%. Samples for (A)
and (B) were collected in mid-exponential phase (***p<.001; ****p<.0001).
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when the ATP synthase inhibitor DCCD was added to the medium in early exponential
phase (Figure 3.12B). Conversely, DCCD had little effect on growth in CDMG or TSB
(Figure 3.12C and 3.12D). Collectively, these experiments suggest that ATP generated
via both substrate level phosphorylation and oxidative phosphorylation is required for
growth in CDM and the importance of the PTA-AckA pathway under these conditions is
most likely linked to the reduced rate of respiration.
Growth of gudB and ackA mutants in CDM is impaired under anaerobic growth.
The infection model proposed by Spahich and colleagues suggests that S.
aureus growing under mild NO stress within an anoxic, glucose-depleted abscess
requires both lactate and peptides. Thus, we assessed whether gudB and ackA were
also required for growth in CDM under anaerobic growth conditions. JE2 was grown in
CDM with or without lactate and/or nitrate, which was used as a terminal electron
acceptor. These experiments demonstrated that enhanced growth was only observed in
CDM containing lactate and nitrate as previously described (10, 11) (Figure 3.13A).
Thus, JE2 gudB::NΣ and JE2 ackA were grown in CDM containing lactate and nitrate.
As predicted, no growth was observed for either of these mutants (Figure 3.13B).
S. aureus does not utilize proline or arginine during growth in CDMG.
During our initial studies with growth in CDM, we found that several differences
were noted if 14 mM glucose was added to the medium. First, aerobic growth of S.
aureus JE2 in CDMG reached an OD600 maximum of approximately 5.5 following 6 hours
of growth at which time glucose was exhausted from the medium (Figure 3.14A). In
contrast to growth in TSB (106) and CDM (Figure 3.1), acetate was not completely
consumed from CDMG suggesting that growth arrest and subsequent acetate oxidation
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Figure 3.12. Importance of aerobic respiration during growth in CDM. Aerobic
growth of JE2, JE2 qoxB::NΣ, and JE2 nrd2::NΣ in CDM (A). Growth of JE2 in CDM
following the addition of the ATP synthase inhibitor DCCD in early exponential phase
(B). Growth of JE2 in CDMG following the addition of the ATP synthase inhibitor
DCCD in early exponential phase (C). Growth of JE2 in TSB following the addition of
the ATP synthase inhibitor DCCD in early exponential phase (D). Data represents
means ± SEM of three biological replicates.
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Figure 3.13. Importance of anaerobic respiration during growth in CDM.
Anaerobic growth (24 hour) of JE2 in CDM containing either 3 mM sodium
nitrate or 0.5% lactate (CDML) (A). Anaerobic growth (24 hour) of JE2, JE2
gudB::NΣ, and JE2 ackA::NΣ grown in CDM containing sodium nitrate (3 mM)
and lactate (0.5%) (B). Data represents means ± SEM of three biological
replicates.
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via the TCA cycle was halted due to depletion of critical amino acids or other C4/C5
compounds as previously discussed, although the exact mechanisms are not clear
(Figure 3.14A) (111). Amino acid analysis of spent medium demonstrated that aspartate,
glutamate, lysine and the glucogenic amino acids alanine, serine, glycine and threonine
were rapidly depleted from the medium (Figure 3.15). However, the remaining amino
acids, including arginine, histidine and proline that are known to generate glutamate
during growth in CDM, were incompletely utilized following 12 hours of growth. In fact, a
mutation in gudB had little effect on growth in CDMG in contrast to that observed with
growth in CDM (Figure 3.14B). As discussed previously, investigations have shown that
arginine and proline catabolism is repressed via CcpA and carbon catabolite repression
(5, 41). However, following glucose consumption at 6 hours of growth, rapid arginine
and/or proline depletion was not observed. Furthermore, no growth was observed in
CDMG when proline (CDMG-P) or arginine (CDMG-R) was subtracted from the medium
(Figure 3.14C). In contrast, the lack of glutamate in CDMG (CDMG-E) did not result in a
significant growth defect (Figure 3.14C). NMR analysis using

13

C6-glucose confirmed that

glucose was metabolized to synthesize glutamate, thus facilitating growth in CDMG-E
(Figure 3.16). However, almost undetectable levels of
were detected during growth with CDMG containing

13

13

C labeled arginine or proline

C6-glucose confirming previous

data demonstrating that arginine and proline need to be acquired from exogenous
sources when S. aureus grows on preferred carbon sources such as glucose (5, 41).
Collectively, these data suggest that growth of S. aureus in CDMG results in rapid
utilization of glucose serine, threonine, alanine, glycine, glutamate, lysine and aspartate.
However, proline and arginine, key amino acids that fuel glutamate synthesis when
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Figure 3.14. Growth of S. aureus JE2 in CDMG. Aerobic growth of JE2 in
CDMG displaying glucose consumption and acetate, ammonia, and lactate
production (A). Growth of JE2 and JE2 gudB::NΣ in CDMG (B) and JE2 in CDMG,
CDMG lacking arginine (CDMG-R), CDMG lacking glutamate (CDMG-E) and CDMG
lacking proline (CDMG-P) (C). Data represents means ± SEM of three biological
replicates.
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Figure 3.15. Amino acid consumption of JE2 following growth in CDMG. JE2
was grown aerobically in CDMG and amino acid concentrations (mM) were measured
from the supernatant at 0, 4, 8 and 12 hours of growth.
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NMR Peak intensity of CDMG supplemented with 13C labeled
glucose. Metabolites derived from [U-13C6] glucose following aerobic growth in
CDMG based on an analysis of triplicate 2D 1H-13C HSQC experiments.. Metabolites
were assayed in early, mid or late exponential growth.

Figure 3.16.
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grown in CDM, are not extracted from the medium. Furthermore, it is unclear how lysine
is rapidly utilized during growth in CDMG as pathways that function to catabolize lysine
were not identified in S. aureus FPR3757 (Table 1.1).
Discussion
Our knowledge of how S. aureus proliferates within multiple niches of the host is
limited. Nevertheless, recent studies have found that S. aureus can adapt to changing
carbon sources and oxygen availability found within specific organ systems. For
example, Hammer and colleagues determined that S. aureus defective in aerobic
respiration were unable to mediate infection in the heart or liver, but colonization and
abscess formation in the kidney was unaffected (4). Complementing these findings, S.
aureus defective in anaerobic fermentation were less virulent than wildtype in a mouse
model of kidney infection (3). Additionally, mutants defective in CcpA are less effective at
infecting the liver where glucose is abundant, but infection burden in the kidney is not
affected (5). Thus, taken together, these data suggest that S. aureus uses distinct
central metabolic pathways to adapt to different carbon or oxygen sources that are
available within the organ system or site of infection.
An elegant model has emerged demonstrating how S. aureus survives within a
staphylococcal abscess (10). The antimicrobial action of NO occurs at multiple nodes of
central metabolism including the TCA cycle and respiration. However, the NO
concentration at the center of staphylococcal abscesses is thought to be below 1 µM
allowing respiration and other metabolic processes to be functional (103, 114).
Furthermore, glucose is depleted due to phagocytic cell activity whereas lactate
concentration is abundant due to excretion during staphylococcal growth (10, 104).
Thus, the major carbon sources for S. aureus at the center of abcesses are lactate and
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peptides. Lactate is utilized via LQO that generates pyruvate and subsequently acetate
via Pta/AckA whereas, peptides provide a carbon source for gluconeogenesis. The goal
of this manuscript was to assess amino acid catabolism and to determine the importance
of particular amino acid catabolic pathways during growth without glucose or other
preferred carbon sources.
Bioinformatic analyses of the USA300 LAC (50) and other staphylococcal
genomes in public databases found that S. aureus has the potential ability to catabolize
11 amino acids to either pyruvate, oxaloacetate, or 2-oxoglutarate (Table 1.1). Growth in
CDM and subsequent amino acid analysis verified these predictions for 10 of the 11
amino acids. The lone amino acid not catabolized, but predicted based on bioinformatics
analyses, was cysteine. This may be because CDM contains MgSO4 as a sulfur source.
It is well established that S. aureus cannot utilize sulfate, sulfite, or sulfonates as the
source of sulfur in cysteine biosynthesis whereas it can use thiosulfate, sulfide, or
glutathione (115). Thus, we predict that a feedback mechanism exists for repressing
cysteine catabolism if an appropriate sulfur source for cysteine synthesis is not present.
In addition, we observed that lysine was catabolized when S. aureus was grown in
CDMG, but not CDM. Some species are known to ferment lysine to acetate (116), but
metabolic pathways to perform this function are not immediately recognized in the S.
aureus genome.
Glutamate is the major amino donor for most anabolic enzymatic reactions and
yet also functions as a key intermediate in carbon metabolism (12, 25). Our results
suggest that glutamate, and those amino acids that can be converted into glutamate,
serve as central carbon sources to facilitate growth in media lacking a preferred carbon
source such as glucose. First, glutamate dehydrogenase (GudB), an enzyme that
catalyzes the conversion of glutamate to 2-oxoglutarate, is required for growth in CDM.
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In addition, all enzymes (excluding Mqo1, which is rescued by anaplerotic reactions
generating oxaloacetate) that function in the TCA cycle downstream of 2-oxoglutarate
are required including phosphoenolpyruvate carboxykinase (PckA) that generates PEP
from oxaloacetate. Thus, glutamate fuels the TCA cycle allowing subsequent
gluconeogenic reactions and presumably serves as the major amino group donor to
cellular reactions.
Second, although NMR analysis found that 13C carbon from all of the amino acids
tested eventually was incorporated into glutamate, only mutations in those genes that
code for enzymes that function to generate glutamate from proline or histidine resulted in
a significant growth defect. Outside of arginine, all other amino acids must generate
glutamate via the TCA cycle and glutamate synthase (GOGAT). However, a mutation in
gltB (encoding large subunit of GOGAT; Figure 3.4U) conferred no growth defect in
CDM suggesting the importance of glutamate synthesis from other amino acids besides
proline and histidine is minimal. As indicated by NMR, arginine can also directly be
converted to glutamate by the arginase pathway (RocF-RocD-RocA) (Figure 3.3).
Alternatively, independent of RocF, arginine deiminase (57) can synthesize ornithine
from arginine, which can then be catabolized to glutamate via RocD and RocA.
However, individual rocF (Figure 3.4E) and arcA1/arcA2 (Figure 3.4Q) mutants did not
have a growth defect in CDM whereas a rocF/arcA1/arcA2 (Figure 3.4V) mutant only
had a post-exponential growth defect suggesting that arginine catabolism does not
significantly contribute to exponential growth. However, it was surprising to note that a
rocD mutant had a similar growth phenotype in CDM as the rocA mutant (Figure 3.4WX); RocD converts ornithine, which can be synthesized from arginine via RocF, to P5C
(Figure 3.3). Since the rocF (Figure 3.4E) mutant did not have a significant growth
defect, one would predict that a rocD mutant would phenocopy a rocF mutant. S. aureus
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also encodes a nitric oxide synthase (nos), which catalyzes the formation of citrulline
from arginine generating NO (62).

Thus, it is possible that arginine is primarily

catabolized via NOS and not arginase or arginine deiminase during growth in CDM, but
this is currently unknown.

Nevertheless, complementing these genetic findings,

comparison of NMR peak intensities suggested that glutamate synthesis via proline was
approximately five-times and six-times that synthesized from arginine in exponential and
post-exponential phase, respectively, and approximately five-times and 2.5-times that
synthesized from histidine in exponential and post-exponential phase, respectively
(Figure 3.8A-D). Thus, as our NMR and amino acid utilization data demonstrate,
histidine is utilized after proline is limiting. Collectively, our data suggest that proline is
the primary substrate for glutamate synthesis during exponential phase and histidine is
utilized once proline is limiting. Furthermore, arginine is a minor source of glutamate
synthesis in both exponential and post-exponential phases of growth.
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Chapter 4

Regulation of Glutamate Biosynthesis in Staphylococcus aureus
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Introduction
Bacterial survival depends on the ability of the organism to sense and respond to
environmental stresses such as temperature and pH fluctuations, as well as alterations
in nutritional availability and quality. As carbon and energy sources within specific host
niches vary, bacteria must be able to efficiently utilize available nutrients to survive.
Pathogenic bacteria exhibit a wide range of central metabolic capabilities, allowing the
bacteria to persist within the human host even when stressful environments are
encountered. Global regulators such as CcpA and CodY are responsible for modulating
the metabolic response to changing environmental conditions, assuring that nutrient and
energy requirements are fulfilled (117, 118).
While commonly thought of as the building blocks of proteins, amino acids can
be utilized as substrates for a variety of bacterial cell processes depending on the
nutrient availability of the surrounding environments (43). It has been established in
several gram-positive bacteria that arginine catabolism via ADI generates ammonia for
pH homeostasis and ATP to fuel cell processes (15, 16, 57). B. subtilis has the ability to
use amino acids, such as arginine and proline, as sole carbon or nitrogen sources in
nutrient-limiting conditions (32, 44-46, 48).

Indeed, in the previous chapter it was

demonstrated that S. aureus utilizes proline, histidine, and arginine as substrates for
glutamate synthesis in the absence of glucose, therefore providing carbon for TCA cycle
activity and gluconeogenesis.
CcpA Regulation
Because of the diverse capabilities of amino acids, their catabolic pathways are
under the control of multiple layers of regulation. Regulation of amino acid catabolism
ensures the transcription of only those genes necessary for the efficient utilization of
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available nutrient sources, which avoids wasting energy by synthesizing unnecessary
macromolecules. Most bacteria can use various compounds as carbon sources,
including amino acids.

Carbon catabolite regulation ensures that secondary carbon

sources are not utilized when preferred carbon sources, such as glucose, are in
abundance, thus, preventing energy expenditure as a result of the expression and
activity of unnecessary catabolic systems (1, 119, 120). In pathogenic bacteria, carbon
catabolite repression has also been linked to virulence factor expression as the proteins
encoded by virulence genes are often involved in nutrient acquisition/utilization (120).
The catabolite regulator, CcpA, is highly conserved among low-G+C, grampositive bacteria including B. subtilis and S. aureus (121).

When preferred carbon

sources such as glucose are transported into the cell, the accumulation of ATP and the
glycolytic intermediates fructose-1,6-bisphosphate (FBP) and glucose-6-phosphate (Glu6-P) leads to the phosphorylation of the HPrK kinase/phosphorylase at Ser-46 (122124). Phosphorylation at this position results in an interaction with CcpA, which in turn
binds to catabolite responsive elements (cre) within promoter/operator regions, thereby
enhancing or repressing expression of the target gene (125-127). In B. subtilis, more
than 100 genes that function in carbon acquisition and metabolism are CcpA regulated
(12). Similarly, the CcpA regulon in S. aureus spans hundreds of genes involved in
carbon metabolism.

Several genes regulated by CcpA are involved in amino acid

metabolism, including argGH, rocD, rocF, rocA, and ald (5, 37, 41, 128). Furthermore,
CcpA can also directly or indirectly regulate virulence gene expression in S. aureus (83,
128).
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CodY Regulation
CodY is also a highly conserved global regulator among low-G+C gram-positive
bacteria, responding to nutritional availability (129). CodY is a DNA-binding protein
responding to intracellular concentrations of two classes of metabolites: the branchedchain amino acids isoleucine, leucine, and valine (BCAAs) and GTP (130, 131). BCAAs
bind to the GAF domain of CodY and induce a conformational change within CodY,
affecting the C-terminal DNA binding domain and increasing the affinity of CodY for its
DNA-binding sequence, thereby repressing or activating target genes (132).

When

nutrients become limiting, decreasing intracellular BCAA pools signal a transition from
exponential- to stationary-phase growth and result in a decrease in affinity with the CodY
GAF domain, which in turn decreases the affinity of CodY-DNA binding. Similarly, CodY
senses the energy status of the cell via interaction with GTP, sensing intracellular GTP
concentrations. However, the location of the GTP binding site of the S. aureus CodY
has not been identified (133).
In S. aureus, CodY directly or indirectly controls the expression of over 200
genes, including those involved in metabolism and virulence, thus linking nutrient
availability to virulence.

CodY directly regulates genes involved in central and amino

acid metabolism during nutrient limitation, prioritizing nutrient uptake and biosynthesis to
ensure survival. Indeed, genes involved in carbon overflow metabolism and the TCA
cycle, such as pyruvate carboxylase and 2-oxoglutarate dehydrogenase, were repressed
during nutrient-rich, exponential-phase growth. Similarly, CodY repressed several amino
acid biosynthetic pathways, including glutamate synthase, in nutrient-rich conditions
(134). Regulation via CodY allows the organism to scavenge available nutrients for
energy and biomass production, before diverting carbon and nitrogen towards
biosynthesis of essential building blocks such as amino acids (135). In this chapter, we
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utilized genetic and transcriptional studies to investigate the regulation of glutamate
biosynthesis via the substrates proline, arginine, and histidine in S. aureus USA300 JE2.
Results
putA, rocD, hutU, rocA, gudB, and rocF are regulated via carbon catabolite repression
and CcpA.
The studies described in chapter 3 suggest that proline and arginine catabolism
is dependent upon carbon catabolite repression. Indeed, previous studies demonstrated
that the interconversion of proline and arginine is repressed via CcpA at rocF, rocD, and
putA in the presence of glucose (5, 41) indicating those amino acids that can be
converted to glutamate can be used as alternative carbon sources. Therefore, it was
hypothesized that the conversion of histidine to glutamate in addition to the conversion
of arginine and proline to glutamate via pyrolline-5 carboxylate and RocA and the
subsequent conversion of glutamate to 2-oxoglutarate via GudB would also be CcpA
repressed as these reactions would only be necessary if there were no other preferred
carbon sources available (Figure 3.3). Therefore, northern blots were utilized to assess
transcription of putA, rocD, hutU, rocA, gudB, and rocF in both JE2 and JE2 ccpA::tetL
following growth in CDMG and CDM. These experiments revealed that putA, rocD, rocA,
gudB, and rocF transcription was induced after glucose was exhausted from CDMG
(post-exponential growth; Figure 4.1A). In addition, as expected, transcription of putA,
rocD, rocA, gudB, and rocF in exponential growth was ccpA-dependent as transcription
was detected in JE2 ccpA::tetL following exponential growth in CDMG (Figure 4.1A).
Furthermore, transcription of putA, rocD, rocA, gudB, and rocF was detected during
exponential growth in CDM, which was expected as CDM contains only amino acids as
carbon sources (Figure 4.1B). Therefore, repression by CcpA should be alleviated.
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Figure 4.1. Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and
hutU following growth in CDMG and CDM. Northern analysis was
performed with RNA isolated from exponential (early) and post-exponential
(late) phases of growth (both CDMG (A) and CDM (B)) from JE2 and JE2
ccpA::tetL. C. Northern analysis of hutU transcription in JE2 from 8 hr to 10 hr
of growth. JE2 ccpA::tetL late RNA was used as a positive control. Equal
loading of RNA was ensured via staining of the RNA gel with ethidium bromide
and visualization of the 16s and 23s rRNA (data not shown).
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Transcription of hutU, however, was only detected in JE2 ccpA::tetL in
exponential phase but not in exponential phase of wildtype JE2. Based on the NMR and
amino acid utilization data (Figure 3.7 and 3.2), we predicted that hutU transcript would
be detected in post-exponential phase following proline and arginine depletion in CDM.
Indeed, hutU transcription was detected by 12 hours of growth in wildtype JE2 (Figure
4.1C).

In addition, hutU transcripts were not detected in CDMG, even in the ccpA

mutant. These data may suggest that growth arrest occurs in CDMG before potentially
multiple regulatory networks induce hutU expression. Indeed, histidine catabolism in B.
subtilis is regulated via both CcpA and CodY (70, 136).

Collectively, these data

demonstrate that pathways that function to fuel glutamate catabolism, and gudB, which
fuels the TCA cycle from glutamate, are all regulated by CcpA and are induced only
when glucose is not present in the medium.
CodY regulates proline, arginine, and histidine utilization pathways
Previous studies of CodY regulation in S. aureus have determined that over 200
genes are directly or indirectly regulated by CodY, including many of those involved in
amino acid metabolism and transport (134). Recent studies from Waters and colleagues
demonstrated that regulation via CodY in S. aureus allows for prioritization of nutrient
uptake and biosynthesis during growth with limited or varying carbon and nitrogen
sources. They constructed codY allelic exchange mutants with varying degrees CodY
activity due to point mutations at conserved arginine and glycine residues within the ILVbinding pocket.

These studies demonstrated that amino acid uptake genes were

generally more sensitive to changes in CodY activity than their cognate biosynthesis
genes, allowing the pathogen to scavenge the surrounding environment for nutrients
before utilizing carbon, nitrogen, and energy for their biosynthesis. Furthermore, these
studies demonstrated that not all biosynthesis pathways are regulated at the same level
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of CodY activity.

For example, although lysine, methionine, and threonine are all

synthesized from aspartate, lysine and methionine biosynthetic genes were expressed
with only minor reductions in CodY activity compared to threonine biosynthetic genes
(135). Lysine can be utilized as a substrate for peptidoglycan synthesis (137, 138);
therefore it is possible that minor changes in CodY activity affects lysine biosynthesis to
support both protein production and peptidoglycan synthesis (135). The sensitivity of
methionine biosynthesis to CodY activity could reflect adaptation of S. aureus to its host,
as methionine is limited in physiological fluids (135, 139, 140).

Collectively, these

studies demonstrate a spectrum of CodY activity regulates S. aureus metabolism,
prioritizing nutrient uptake and biosynthesis in nutrient depleted environments.
The studies described in the previous chapter suggest that when grown in the absence
of glucose, S. aureus utilizes glutamate, and those amino acids that can be utilized as
substrates for glutamate synthesis (proline, arginine, and hisitidine), as carbon sources
to fuel TCA cycle activity and gluconeogenesis. Growth and NMR studies demonstrated
that proline, arginine, and histidine all serve as substrates for glutamate synthesis in
glucose limiting conditions (Figure 3.6 and 3.7). Proline utilization via PutA and RocA
appeared to be the major source of glutamate, as the putA and rocA transposon mutants
had significant growth yield defects when grown in CDM lacking glutamate (CDM-E)
compared to wild type JE2; whereas mutations in the pathways utilizing arginine (rocF)
and histidine (hutU) had only moderate growth defects compared to wild type JE2 grown
in CDM-E. Furthermore, the relative amount of glutamate generated from proline was
approximately five-fold greater than the amount generated from arginine (Figure 3.8).
As recent studies have suggested that CodY regulates preferential uptake and utilization
of nutrients (135), we hypothesized that CodY would function to regulate proline,
arginine, and histidine utilization as substrates for glutamate synthesis when grown in
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carbon limiting conditions. Indeed, the codY transposon mutant had significant growth
defects when grown in CDM and CDM-E, suggesting that CodY positively affects the
transcription of glutamate synthesis pathways (Figure 4.2). Therefore, northern blots
were utilized to assess the transcription of rocA, putA, rocD, hutU, rocF, and gudB in
both JE2 and JE2 codY::ΝΣ following growth in CDM. These experiments revealed a
decrease in induction of putA and rocA in the codY mutant when compared to wild type
JE2 during exponential-growth in CDM (Figure 4.3A).

Furthermore, northern blot

assessment of the transcription of these genes during growth in CDMG demonstrated a
complete loss of not only putA and rocA transcription, but also a loss of rocD and gudB
transcription, following glucose exhaustion in the codY mutant when compared to wild
type JE2 (Figure 4.3B). These data suggest that in the absence of CcpA repression,
CodY activity positively regulates transcription of genes involved in the synthesis of
glutamate via proline and arginine catabolism.
As previously described, hutU transcription was predicted to occur in JE2 during
stationary phase following proline and arginine depletion in CDM, however hutU
transcription was only detected during exponential growth in a ccpA mutant.

We

hypothesized CodY would also be functioning to regulate hut transcription during growth
in CDM, as both CcpA and CodY function to repress histidine catabolism in B. subtilis.
Indeed, hutU transcripts were detected during post-exponential growth in JE2 codY::ΝΣ,
suggesting that both CodY and CcpA function to repress histidine catabolism in S.
aureus (Figure 4.3A).

Collectively, these data suggest that when preferred carbon

sources like glucose are limiting and CcpA repression is alleviated, CodY activity
regulates glutamate synthesis via induction of proline and arginine catabolic genes,
while repressing histidine catabolism.
Regulation via the arginine transcriptional regulators ArgR1, ArgR2, and AhrC
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Figure 4.2. Growth in CDM-E. (A) Aerobic growth of JE2 and JE2 codY::NΣ
in CDM-E. (B) Growth of JE2 and JE2 argR1::NΣ CDM-E. Data represents
means ± SEM of three biological replicates.
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Figure 4.3. Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and
hutU in S. aureus JE2 and JE2 codY::ΝΣ. Northern analysis was performed
with RNA isolated from exponential (early) and post-exponential (late) phases
of growth in CDM (A) and CDMG (B) from JE2 and JE2 codY::ΝΣ. Equal
loading of RNA was ensured via staining of the RNA gel with ethidium bromide
and visualization of the 16s and 23s rRNA (data not shown).
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In B. subtilis, the expression of both arginine and proline catabolic genes are
controlled by multiple transcriptional regulators, sensing several environmental cues. In
addition to regulation via CcpA sensing the availability of glucose and CodY sensing the
nutritional status of the cell through assessments of BCAA levels, as well as the energy
status of the cell via intracellular GTP concentrations, B. subtilis encodes regulators that
sense the availability of specific amino acids. Proline can serve as the sole carbon or
nitrogen source in B. subtilis through utilization of the putBCP operon.

The

transcriptional activator, PutR, induces the expression of this operon in the presence of
proline. However, CodY activity will repress putBCP expression by displacing PutR (46).
B. subtilis can also utilize arginine as a sole carbon or nitrogen source via the arginase
pathway (rocABC and rocDEF operons), which is induced via the positive transcriptional
regulator RocR when in the presence of arginine, ornithine, citrulline, or proline (32, 48).
A second regulatory protein, AhrC, also acts a positive regulator of these operons in the
presence of arginine, while repressing the arginine biosynthetic arg operon (141).
As previously discussed, the S. aureus genome does not encode orthologous
putR or rocR genes, however, it does encode the arginine transcriptional regulator,
ahrC. Arginine transcriptional regulation was first described in Esherichia coli, in which
the transcriptional regulator, ArgR, repressed the transcription of the arginine
biosynthetic arg operon. In the presence of arginine, ArgR binds to one or more 18-bp
palindromic sequences referred to as ARG boxes, repressing transcription of arg genes
(142). In B. subtilis, the ArgR-type regulator, AhrC, was shown to not only repress
transcription of arginine biosynthesis but also activate arginine catabolism via the
arginase pathway in the presence of arginine (143).

In Lactococcus lactis, another

gram-positive bacterium, both ArgR and AhrC have been shown to regulate arginine
metabolism. Here, in the absence of arginine ArgR has a higher affinity for the promoter
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of the arginine catabolic arc operon than it does for the biosynthetic arg operon, possibly
due to additional ARG box binding sites within the arc promoter. This prevents arginine
degradation via the ADI pathway, while allowing for de novo arginine synthesis via the
arg operon. The addition of arginine results in the formation of an AhrC-ArgR protein
complex, with high affinity for the ARG box binding sites within the promoter of the arg
promoter. ArgR repression of the arc promoter is alleviated as it complexes with AhrC,
repressing the expression of arginine biosynthetic genes and allowing for arginine
catabolism via the ADI pathway (54).
S. aureus USA300 JE2 has three ArgR-type transcriptional regulators, AhrC,
ArgR1, and ArgR2. The transcriptional regulator AhrC, which shares 61% amino acid
sequence homology to the B. subtilis AhrC protein, is encoded by ahrC on the
chromosome in an operon with the DNA recombination gene, recN. ArgR1 and ArgR2
are encoded by the genes, argR1 and argR2, which are monocistronic units of the two
ADI operons found within the S. aureus USA300 JE2 genome.

The native ADI operon

contains the gene argR1, encoding the native arginine transcriptional regulator, ArgR1.
While the acquired arginine catabolic mobile element (ACME) encodes a second ADI
operon, and therefore a second arginine transcriptional regulator, ArgR2 (Figure 4.4)
(50). As AhrC and ArgR function to regulate utilization of arginine as alternative carbon
and nitrogen sources in other gram-positive bacteria, we hypothesized they may have
similar functions in S. aureus when grown in CDM and utilizing amino acids as carbon
sources. Northern blots were utilized to assess transcription of putA, rocD, hutU, rocA,
gudB, and rocF in JE2, the transposon mutants JE2 argR1::ΝΣ and JE2 argR2::ΝΣ, and
JE2 ΔahrC following growth in CDM (Figure 4.5, 4.7, and 4.8). An in-frame, markerless
deletion was constructed in JE2 ΔahrC to avoid any polar mutations with recN. These
experiments revealed that in S. aureus, the arginine repressor ArgR1 functions to
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Figure 4.4 Comparison of native (argR1 – arcR1) and acquired (argR2 –
arcC2) ADI operons and arginine transcriptional regulators (argR1,
argR2, and ahrC). Percentage of amino acid identity between genes of the
native and acquired ADI operon and between all three arginine transcriptional
regulators are shown.
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Figure 4.5. Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and
hutU in S. aureus JE2 and JE2 argR1::ΝΣ. Northern analysis was
performed with RNA isolated from exponential (early) and post-exponential
(late) phases of growth in CDM (A) and CDMG (B) from JE2 and JE2
argR1::ΝΣ. Equal loading of RNA was ensured via staining of the RNA gel
with ethidium bromide and visualization of the 16s and 23s rRNA (data not
shown).
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regulate proline catabolism via putA transcription as JE2 argR1::ΝΣ had decreased
expression of putA during early-exponential growth when compared to wild type JE2
(Figure 4.5A). Indeed, a mutation in argR1 results in a significant growth yield defect,
similar to a codY mutant, compared to wild type JE2 when grown in CDM-E (Figure 4.6).
Furthermore, putA transcription was also decreased in this mutant during postexponential growth in CDMG (Figure 4.5B). Suggesting that in the absence of carbon
catabolite repression, ArgR1 can function to activate proline catabolism.
As argR2 is an acquired arginine repressor, not native to the chromosome, we
expected to see minimal effects on growth and gene expression in the argR2 transposon
mutant when grown in CDM. The argR2 mutant had a similar growth phenotype as JE2
when grown in CDM, however, a moderate growth yield defect was observed compared
to JE2 when grown in CDM-E, suggesting regulation of glutamate synthesis via ArgR2.
Northern blot analysis revealed increased rocF transcription during early-exponential
growth and delayed induction of rocA transcription in the argR2 mutant compared to wild
type JE2 when grown in CDM (Figure 4.7). While in the ahrC mutant, rocA and rocD
had increased expression during early-exponential growth when compared to wild type
JE2, suggesting ArgR2 and AhrC are both functioning to regulate arginine catabolic
pathways (Figure 4.8). It is also worth noting that in an ahrC mutant, hutU transcription
was observed during late-exponential growth, similar to what was seen in the codY
mutant, indicating AhrC activity also regulates histidine catabolism (Figure 4.3A).
Discussion
Bacteria are able to adapt efficiently to a wide range of nutritional environments
through the use of regulatory systems linking nutritional availability to gene expression.
B. subtilis integrates the activities of several global regulators, including CcpA and CodY,
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Figure 4.6. Growth of S. aureus JE2 an arginine transcriptional regulators in
CDM and CDM-E. Aerobic growth of JE2 argR1::NΣ, JE2 argR2::NΣ, and JE2
ΔahrC in CDM (A) and CDM-E (B) in comparison to wild type JE2. Data represents
means ± SEM of three biological replicates.

99

Figure 4.7. Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU
in S. aureus JE2 and JE2 argR2::ΝΣ. Northern analysis was performed with RNA
isolated from exponential (early) and post-exponential (late) phases of growth in
CDM (A) and CDMG (B) from JE2 and JE2 argR2::ΝΣ. Equal loading of RNA was
ensured via staining of the RNA gel with ethidium bromide and visualization of the
16s and 23s rRNA (data not shown).
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Figure 4.8. Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU
in S. aureus JE2 and JE2 ΔahrC. Northern analysis was performed with RNA
isolated from exponential (early) and post-exponential (late) phases of growth in
CDM (A) and CDMG (B) from JE2 and JE2 ΔahrC . Equal loading of RNA was
ensured via staining of the RNA gel with ethidium bromide and visualization of the
16s and 23s rRNA (data not shown).

101
to control gene expression according to what nutrients are available (12). Pathogenic
bacteria often contend with its host restricting nutrient availability, thus they have
evolved or acquired virulence factors that aid in nutrient acquisition through host tissue
destruction.

Often, these bacteria utilize the same regulators of metabolism as

regulators of virulence, coordinating nutrient availability with virulence. Coordination of
regulation in this way reserves expression of destructive virulence factors for nutrient
limiting environments (12, 117). In S. aureus, virulence and metabolic gene expression
have been linked to both CodY and CcpA activity, allowing this pathogen to maximize
the limited nutritional resources available within its host. Li et al. demonstrated a link
between carbon catabolite repression via CcpA and virulence, as a ccpA mutant
demonstrated attenuated virulence in a liver abscess model of infection compared to
wild type, indicating the regulation of carbon source utilization is important during
pathogenesis (5).

Furthermore, S. aureus CodY has been shown to regulate gene

expression through a spectrum of CodY activity. As nutrients begin to be depleted from
the environment, CodY sequentially activates the expression of virulence genes
(typically via loss of repression) encoding proteins that destruct host tissues, as wells as
nutrient scavenging/metabolism genes allowing the bacterium to acquire and utilize the
available nutrients found within the degraded tissue (135).
Understanding the interwoven metabolic and regulatory networks within S.
aureus in their entirety requires large data sets and a systems biology approach;
however, defining individual regulatory nodes provides useful information as to when
these metabolic networks may be functional during pathogenesis. We have previously
described an emerging model of S. aureus abscess formation where it is hypothesized
that viable cells within the abscess must utilize lactate, peptides, and free amino acids
as carbon and energy sources (10, 11, 104).

In our assessment of amino acid
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catabolism we determined that S. aureus utilizes glutamate, and those amino acids that
can be converted into glutamate, as central carbon sources.

Carbon catabolite

repression prevents energy expenditure by repressing the expression and activity of
unnecessary catabolic systems when preferred carbon sources such as glucose are in
abundance (1, 119, 120).

It has been well documented that the pathways

interconverting proline and arginine are under repression by the catabolite repressor,
CcpA, in the presence of glucose as well as their conversion to glutamate via rocA (5,
37, 41, 128). Therefore, it was of no surprise to find induction of putA, rocD, rocF, rocA,
and gudB expression following the exhaustion of glucose in CDMG (Figure 4.1A). The
increased expression in JE2 ccpA::tetL compared to wild type JE2 during earlyexponential growth in CDMG confirms this repression is ccpA dependent (Figure 4.1A).
Furthermore, as predicted, transcription of putA, rocD, rocA, gudB, and rocF was
detected during exponential growth in CDM (Figure 4.1B), further indicating that
glutamate, as well as proline and arginine, can be utilized as carbon sources during
nutrient limitation.
Bacterial growth is dependent on the availability of nutrients.

Nutritional

adaptation allows for the expression of genes involved in the transport and catabolism of
the nutrients that are available in the environment. The global regulator, CodY, has
been well documented to regulate amino acid metabolism in response to nutrient
starvation by responding to the intracellular concentration of both BCAAs and GTP.
During the transition from exponential- to stationary-phase growth,

decreasing

BCAA

and GTP concentrations lead to derepression of CodY regulated genes (129-131).
Waters and colleagues have developed a model where a spectrum of CodY activity
promotes growth in varying BCAA and GTP concentrations. It was determined that
under conditions of increasing nutrient depletion, CodY sequentially turns on genes
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required for transporting nutrients, before turning on genes involved in the de novo
synthesis of the compound. Thus, prioritizing nutrient uptake and catabolism, ensures
that energy and resources are not wasted on synthesizing nutrients that are available in
the environment (135).
In studies performed by Waters et al., transcriptional profiling via RNA-seq
experiments indicated that transcripts of the proline transporters, proP and putP, were
among the first to be induced following nutrient depletion (135) suggesting that proline
catabolic genes would also be induced by CodY during nutrient limitation.

Indeed,

northern blot experiments demonstrated induction of glutamate synthesis genes via
proline catabolism is CodY-dependent. In the absence of glucose, and therefore when
CcpA repression is alleviated, a codY mutant demonstrates decreased induction of putA
and rocA, when compared to wild type JE2, suggesting CodY activity facilitates
glutamate synthesis via the activation of proline catabolic genes in the absence of a
preferred carbon source (Figure 4.1). A codY mutant also results in a significant growth
yield defect, similar to that seen in a putA mutant when grown in CDM-E (Figure 4.2),
further suggesting proline catabolism is regulated by CodY activity. Collectively, our
assessments of the induction of glutamate synthesis genes via the catabolism of
arginine and proline suggest that the presence of glucose represses the transcription of
these pathways in a CcpA-dependent manner. In the absence or exhaustion of glucose,
CodY activity leads to induction of the proline catabolic genes, putA and rocA, facilitating
the use of proline as a carbon source.
Regulation of both proline and arginine catabolic pathways leading to the
synthesis of glutamate have been well characterized in B. subtilis. Several transcriptional
regulators have been characterized that function to regulate these pathways, including
PutR, RocR, AhrC, and the aforementioned CcpA and CodY. While S. aureus does not
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encode orthologous PutR or RocR proteins, its genome does encode the arginine
transcriptional regulator, AhrC.

In fact, it has been reported that three arginine

transcriptional regulators, ArgR1, ArgR2, and AhrC, are encoded by the S. aureus JE2
genome (50). As S. aureus arginine and proline synthesis pathways are interconnected
and as these ArgR-type regulators have been shown in several gram-positive organisms
to regulate both arginine anabolism and catabolism (5, 37, 41), we hypothesized one or
more of the ArgR-type regulators encoded by S. aureus JE2 functioned to regulate
proline and arginine catabolism. Growth studies revealed that when grown in CDM-E a
mutation in argR1 resulted in similar growth defects as seen in putA and codY mutants,
indicating this mutant is unable to utilize proline for glutamate synthesis (Figure 4.6).

In

conjunction with these findings, and similar to results seen in the codY mutant, northern
blot analysis demonstrated that after the exhaustion of glucose in CDMG and during
exponential growth in CDM, a mutation in argR1 results in loss of expression of putA
when compared to wild type JE2 (Figure 4.5).

Furthermore, we predicted that a

mutation in argR2 would have little effect on expression of these pathways, as it is an
acquired regulator, not native to the chromosome. Much to our surprise, a mutation in
argR2, as well as a mutation in ahrC, resulted in moderate growth defects when grown
in CDM-E (Figure 4.6) and decreased putA expression following glucose exhaustion
when grown in CDMG, albeit less pronounced than the argR1 mutant (Figure 4.7B and
4.8B). These data suggest that all three arginine regulators, in the absence of glucose
and carbon catabolite repression, have the ability to induce putA expression, thus
facilitating activation of proline catabolism. A mutation in argR2 also resulted in delayed
expression of rocA and increased rocF transcription during exponential growth in CDM,
while an ahrC mutant had increased rocA expression during exponential growth in CDM
when compared to wild type (Figure 4.7A and 4.8A), suggesting these regulators also
have a function in arginine utilization and catabolism.
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While these studies indicate that in the absence of glucose, ArgR1, ArgR2, and
AhrC function in regulating the pathways involved in glutamate synthesis via the
catabolism of proline and arginine, the mechanisms of regulation remain unclear. The
similar lack of growth in CDM-E (Figure 4.2 and 4.6) and loss of expression of putA
during growth in both CDMG and CDM in the argR1 and codY mutants (Figure 4.3 and
4.5) suggest both of these regulators are involved in activation of proline catabolism. As
nutrients become limiting within the environment, CodY typically induces gene
expression through loss of repression due to conformational changes induced by
decreasing BCAA and GTP concentrations. If loss of CodY repression during nutrient
depletion functions to induce transcription of putA, we would expect to see increased
expression of putA in a codY mutant.

However, as we ovserve complete loss of

transcription of putA in the codY mutant we hypothesize induction of an unknown
activator, such as ArgR1, by CodY could result in putA transcription.
We observed similar growth in the argR2 mutant compared to wild type JE2 in
CDM (Figure 4.9); however, moderate growth defects are seen when grown in CDM-E
(Figure 4.6), indicating ArgR2 regulates glutamate synthesis under these conditions.
Indeed, when grown in CDM the argR2 mutant demonstrated increased expression of
rocF during exponential growth, indicating it represses arginase-mediated arginine
catabolism (Figure 4.7A). Delayed expression of rocA in JE2 argr2::ΝΣ when compared
to wild type JE2 during growth in CDM indicates this mutant is not able to utilize proline
or arginine during exponential growth (Figure 4.7A); however, growth defects are not
observed when grown in CDM (Figure 4.9). These data suggest the argR2 mutant is
able to utilize other sources of carbon for growth during early exponential growth, while
arginine and proline may be utilized during post-exponential growth.

Indeed, NMR

analysis to determine the fate of carbon after amino acid uptake and catabolism in this
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mutant would provide useful information as to what pathways are being utilized during
growth in CDM.
We observed few effects on transcription of glutamate synthesis via proline and
arginine catabolism pathways during growth in CDM in the ahrC mutant (Figure 4.8A).
However, we did observe increased hutU transcription during late-exponential growth in
CDM in the ahrC mutant when compared to wild type JE2 (Figure 4.8A). Amino acid
consumption data demonstrated that histidine utilization followed proline and arginine
exhaustion during growth in CDM (Figure 3.2).

While hutU transcription was not

observed in wild type during early or late time points in CDM, it was observed in the
ccpA, codY, and ahrC mutants (Figure 4.1B, 4.3A, and 4.8A). In B. subtilis, repression
of hut transcription by CcpA and CodY ensures histidine catabolism is only active when
absolutely necessary, as histidine synthesis requires an input of 20 high-energy
phosphate bonds (66). Increased transcription during early exponential growth in the
ccpA mutant indicates that even in the absence of a primary carbon source such as
glucose, CcpA still mediates repression of some genes.

We observed increased

transcription of hutU in the codY mutant and ahrC mutants during post-exponential
growth, indicating both of these regulators function to repress histidine catabolism,
however the mechanism of repression remains unclear.
In conclusion, the experiments described above indicate the regulation of
glutamate synthesis via the catabolism of arginine, proline, and histidine involves several
transcriptional regulators, including CcpA, CodY, ArgR1, ArgR2, and AhrC, however the
exact mechanisms of regulation remain unclear. It has been well documented by our
group and others that the pathways leading to glutamate synthesis via proline, arginine,
or histidine degradation are CcpA regulated and not induced in the presence of glucose
(5, 37, 41), thus, indicating these amino acids are utilized as a carbon source in glucose
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deplete environments. These studies also demonstrated that CodY and ArgR1 activity
facilitate the induction of proline catabolism via putA expression. While the mechanism
of putA induction remains unclear, it is possible that as nutrients are depleted from the
environment, CodY activity results in expression of argR1, which in turn induces
transcription of putA, however, further investigation is needed to confirm this hypothesis.
While we are uncertain of the exact functions of ArgR2 and AhrC in the regulation of
these amino acid catabolic pathways, northern blot and growth analyses suggest that
they may function to regulate the sequential utilization of proline, arginine, and histidine.
Indeed, further NMR analysis and transcriptional profiling of these regulator mutants
should provide useful insight into the mechanisms of the regulation of glutamate
synthesis via amino acid catabolism.
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Chapter 5

Concluding Remarks
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Final observations of amino acid catabolism in S. aureus and Future Directions
Pathogenic bacteria must readily adapt to changing carbon and nitrogen sources
to successfully proliferate within their human hosts.

Understanding what metabolic

pathways are required for growth within specific niches may reveal novel avenues for
drug development.

S. aureus is capable of establishing an infection in a variety of

metabolic niches within the human host, most commonly skin and soft tissues. The work
presented in this dissertation contributes to an evolving model of S. aureus survival
within abscesses. To persist within the human host, S. aureus must not only combat
host innate defenses, such as NO production, but must also adapt its metabolic
processes to overcome nutrient limitations at sites of infection (10, 11, 95).

It is

proposed that the major carbon sources available at the center of staphylococcal
abscesses are lactate, excreted from bacterial glucose fermentation during NO stress,
and peptides. S. aureus is able to utilize lactate via lactate quinone oxidoreductast (Lqo)
generating pyruvate and subsequently acetate via the ATP-producing PTA/AckA
pathway; where as peptides are predicted to provide a carbon source for the bacteria to
fuel gluconeogenesis and biomass production (10). The goal of this work was to assess
amino acid catabolism in S. aureus and to determine the importance of particular amino
acid catabolic pathways during growth without glucose or other preferred carbon
sources.
S. aureus encodes pathways to catabolize multiple amino acids, including those
that generate pyruvate, 2-oxoglutarate, and oxaloacetate. The data presented here has
demonstrated that the enzyme GudB, which generates 2-oxoglutarate from glutamate,
and subsequently those amino acids that lead to glutamate synthesis, is essential for
growth in media lacking glucose. We observed that glutamate was primarily synthesized
through catabolism of proline via PutA and RocA during growth in the presence of amino
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acids. These findings contribute to a previously proposed model that predicts that S.
aureus utilizes both host- and self-derived proteases to liberate free proline or prolinecontaining peptides from the fibrin wall when encapsulated within an abscess. A major
constituent of the fibrotic wall encapsulating the bacterial cells is collagen and the
second most abundant amino acid found in collagen is proline (41, 144); thus,
suggesting a reservoir of proline is present at the site of staphylococcal infection (Figure
5.6). Moreover, mutants in the high affinity proline permease, PutP, are less virulent in
animal models of infection (145, 146). Collectively, these data and observations suggest
S. aureus has adapted to the microenvironment of the abscess, utilizing substrates
provided by the fibrotic wall that encapsulates it for growth and persistence. Indeed,
analysis of the proline catabolic putA and rocA mutants and the gudB mutant’s ability to
survive within a murine abscess model is required to determine the functions and
importance of these pathways in vivo. Furthermore, characterization of proteases and
transporters involved in the liberation and consumption of proline proposed to contribute
to this model of abscess formation and persistence would provide evidence that S.
aureus has the ability to utilize proline in nutrient limiting conditions.
The results of the characterization of amino acid catabolism in S. aureus
suggests that growth on amino acids is dependent upon ATP generation from
PTA/AckA, as an ackA mutant was unable to grow in CDM. In addition, a functional
respiratory chain was required for growth. It is not surprising that growth in the presence
of amino acids would require ATP generation from both substrate level phosphorylation
and the electron transport chain as amino acid transport requires ATP and is a more
energy intensive process than carbohydrate transport. However, it is unclear whether
this growth phenotype is due to loss of ATP generation or disruption of intracellular
acetyl-phosphate pools, as acetyl-phosphate is a key coeffector molecule in the cell.
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Growth analysis of a serine dehydratase and alanine dehydrogenase double mutant,
abolishing the cells ability to utilize glucogenic amino acids for pyruvate and subsequent
acetate generation, would provide further information on the contribution of ATP
generation via PTA/AckA to growth on amino acids.
Arginine is proposed to be limiting within abscesses due to utilization by host
innate immune responses and bacterial scavenging, however, its function in S. aureus
pathogenesis remains unclear. It is hypothesized that ADI activity could be important for
pathogenesis, as arginine catabolism via the ADI pathway provides pH homeostasis and
energy generation via ammonia and ATP production to a variety of bacteria, including
staphylococcal species, contributing to the overall fitness of these organisms during
growth in specific niches (16, 55, 57). It is unclear how arginine is utilized in CDM, as
the arcA1/arcA2/rocF triple mutant showed only slight growth yield defects. It is possible
that arginine catabolism via ADI could be contributing to ATP production or pH
homeostasis during growth in the absence of preferred carbon sources as citrulline
formation was detected in NMR analysis of arginine utilization (Figure 3.7). Citrulline is
an intermediate of all three arginine catabolic pathways (argininase, ADI, and NOS
pathways), which can synthesize ATP and ammonia via ArcC. While it is assumed that
transposon mutations in arcA1 and arcA2 facilitate polar mutations, disrupting
transcription of all genes involved in the arc operon, it is possible that the ArcC enzyme
is functional in these mutants, allowing for ATP generation. Growth analysis and murine
abscess models of infection utilizing an arcC1/arcC2 mutant could provide more
knowledge of the contribution of ADI during growth on alternative carbon sources.
Furthermore, growth analysis of a nos mutant could also provide information as to what
pathways are utilizing arginine during growth in these conditions.
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Final observations on regulation of amino acid catabolism
As previously discussed, S. aureus has shown to be a proline and arginine
auxotroph (39), with growth in CDMG lacking either proline or arginine (CDMG-P,
CDMG-R)

being dependent upon alleviation of CcpA repression (5, 37, 41).

Our

studies, and others, have demonstrated that the multiple pathways fueling glutamate
synthesis (via proline, arginine, and histidine), and subsequent conversion to 2oxoglutarate via GudB, are all under the repression of CcpA and only active during
growth on non-preferred carbon sources (5, 37, 41). It was predicated that growth
defects in CDM lacking arginine or proline would be observed in JE2 as CcpA repression
is alleviated. Although moderate defects were observed, JE2 could grow in the absence
of proline in a RocF-dependent manner, suggesting utilization of arginine for both proline
and glutamate synthesis (Figure 5.1A). However, we only observed growth in CDM-R
when ccpA was inactivated (Figure 5.1B). Complementing these findings, NMR analysis
demonstrated that proline utilization does not facilitate arginine synthesis during growth
in CDM. It is unclear how CcpA is functioning to repress arginine biosynthesis in the
absence of arginine. However, the detection of argG transcript, which encodes the urea
cycle enzyme argininosuccinate lyase and is required for arginine biosynthesis, during
post-exponential growth in CDM in both JE2 and the ccpA mutant, demonstrates
arginine biosynthesis is induced after the exhaustion of arginine from CDM during postexponential growth (Figure 5.2A), thus, suggesting another regulator functions to induce
arginine biosynthesis in the absence of arginine. The arginine transcriptional regulator,
AhrC, has been well characterized in B. subtilis, functioning to repress arginine
biosynthesis in the presence of arginine, while simultaneously activating arginine
catabolism via the arginase pathway (143). While we were surprised to determine AhrC
had little effect on the activation of arginine catabolism
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Figure 5.1. Growth of S. aureus JE2 and JE2 ccpA::tetL in CDM and CDM
lacking arginine (CDM-R). Aerobic growth of JE2 ccpA::tetL in CDM (A) and
CDM-R (B) in comparison to wild type JE2. Data represents means ± SEM of
three biological replicates.
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via the arginase pathway during growth in CDM, our data does suggest AhrC is
functioning to repress transcription of arginine biosynthesis under these conditions.
Northern blot analysis of the ahrC mutant during early-exponential growth in CDM
demonstrated increased argG transcription when compared to wild type JE2 (Figure
5.2B). Arginine is still available in the media during early-exponential growth in CDM
(Figure 3.2), suggesting AhrC is repressing arginine biosynthesis in an argininedependent manner. After further analysis of argG transcription, we were surprised to
determine that while ArgR1 had no effect on transcription, ArgR2 is also functioning to
repress argG during growth in CDM (Figure 5.2C and 5.2D). As ArgR2 was acquired
with the addition of the ACME island to the S. aureus USA300 JE2 genome (50), it
would be interesting to compare regulation of argG to strains without the ACME element
or in a JE2 ΔACME mutant.
In most bacteria, arginine is typically synthesized via glutamate catabolism and
the argJBCDFGH pathway. However Nuxoll et al. demonstrated that this pathway in S.
aureus is inactive and that proline serves as a substrate for arginine biosynthesis via
PutA, RocD and the urea cycle, including ArgG, in the absence of CcpA repression (41).
We hypothesized that AhrC could be functioning to repress the argJBCD operon in the
presence of arginine; however, we observed no expression of argJ in the ahrC mutant
(Figure 5.3). Furthermore, we were unable to detect argJ transcript in ArgR1 or ArgR2
during growth in CDM (Figure 5.3). Interestingly, further characterization of the arginine
transcriptional regulators revealed ArgR1, and to a lesser extent ArgR2, function to
activate putA expression after exhaustion of glucose in CDMG (Figure 4.5B and 4.7B).
AhrC, however, repressed putA transcription in an arginine-dependent manner (Figure
4.8), further implicating its function in repression of arginine biosynthesis in the presence
of arginine. Collectively, these results indicate these arginine transcriptional regulators
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Figure 5.2. Transcriptional analysis of argG in S. aureus. Northern
analysis was performed with RNA isolated from exponential (early) and
post-exponential (late) phases of growth in CDM in wild type JE2, JE2
ccpA::tetL (A), JE2 ΔahrC (B), JE2 argR1::ΝΣ (C), and JE2 argR2::ΝΣ (D).
Equal loading of RNA was ensured via staining of the RNA gel with ethidium
bromide and visualization of the 16s and 23s rRNA (data not shown).
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Figure 5.3. Transcriptional analysis of argJ in S. aureus JE2 and the
various regulator mutants. Northern analysis was performed with RNA
isolated from exponential (early) and post-exponential (late) phases of
growth in CDM from JE2, JE2 argR1::ΝΣ, JE2 argR2::ΝΣ, JE2 ΔahrC, JE2
ccpA::tetL, and JE2 codY::ΝΣ. Genomic DNA from JE2 was used as a
positive control to ensure the argJ probe was functional. Equal loading of
RNA was ensured via staining of the RNA gel with ethidium bromide and
visualization of the 16s and 23s rRNA (data not shown).
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have evolved in the regulation of arginine biosynthesis from glutamate catabolic genes
to proline catabolic genes. Perhaps, S. aureus has adapted both its metabolic pathway
preferences and its regulatory mechanisms to utilize proline instead of glutamate, as
proline is potentially in abundance during infection.
The global regulator, CodY, directly or indirectly controls the expression of over
200 genes in S. aureus, including those involved in metabolism and virulence, allowing
the organism to efficiently utilize available nutrient sources and avoiding wasteful energy
expenditure by synthesizing unnecessary macromolecules. CodY regulation of proline
metabolism was recently implicated in studies performed by Waters et al. as proP and
putP genes encoding proline transporters were among the first to be expressed following
nutrient depletion and derepression of CodY (135). Furthermore, the ability to transport
proline has been linked to virulence, as mutants in putP are less virulent in animal
models of infection (145, 146). These data suggest that proline catabolic pathways are
also regulated via CodY derepression and nutrient limitation.

Indeed, our studies

implicated CodY involvement in putA transcription as a codY mutant had decreased
induction of expression after alleviation of repression via CcpA (Figure 4.3).

CodY

activation of genes typically induces gene transcription via loss of repression; therefore,
it is hypothesized that CodY activation of putA expression in the absence of CcpA
repression occurs through derepression of an auxiliary transcriptional regulator, perhaps
one that senses the availability of proline.
Amino acid consumption data indicated that histidine was consumed when
glucose is limiting. Indeed, genetic and NMR analyses demonstrated that histidine can
be utilized as a substrate for glutamate synthesis via the hut genes; thus, it can also
serve as a carbon source in the absence of glucose.

As both CcpA and CodY repress

histidine catabolism in B. subtilis, we predicted they would also be involved in hut
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repression in S. aureus.

Much to our surprise, hut induction was not detected in

northern blot analyses of early- and late-exponential time points during growth of JE2 in
CDM (Figure 4.1), even though NMR studies determined that the presence of histidine
facilitated glutamate synthesis during late-exponential growth (Figure 3.7). However, we
did detect hut transcription in CcpA and CodY mutants, indicating that histidine
catabolism is only induced during carbon and nutritional limitation (Figure 4.1B and
4.3A). Histidine is one of the most expensive amino acids for the cell to synthesize,
requiring an input of 20 high-energy phosphate bonds (66), suggesting it would only be
catabolized during extreme carbon and nutrient limitations. To further suggest histidine
utilization is only induced during times of starvation, AhrC also repressed hut
transcription in an arginine-dependent manner (Figure 4.8).

Figures 5.4 and 5.5

summarize our proposed model of the regulation of the proline, glutamate, and arginine
metabolic pathways in the presence and absence of preferred carbon.

Figure 5.6

depicts the proposed model of S. aureus survival within an abscess.
Future Directions
The work presented in this dissertation provides evidence that proline can be
utilized as a carbon source for bacterial growth in carbon limiting environments via its
conversion to glutamate, which is further utilized to drive TCA cycle activity and
gluconeogenesis, thus, providing the cell with carbon to fuel biomass production. CcpA
repression in the presence of glucose further suggests the importance of the utilization
of glutamate and those amino acids that synthesize glutamate as carbon sources, as
these pathways are only induced during carbon limitation. Further characterization of
the mechanisms of regulation involved in the interconnected pathways of glutamate,
proline, arginine, and histidine metabolism indicated that CodY and the arginine
transcriptional regulators AhrC, ArgR1, and ArgR2 are involved in controlling the
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expression of these pathways. It seems likely that AhrC and ArgR2 function to repress
arginine biosynthesis in the presence of arginine and that CodY activity regulates proline
catabolism during nutrient limitation. Additionally, ArgR1 appears to activate proline
catabolism in a CcpA-dependent manner, however, further experimentation is required
to confirm this hypothesis.

Indeed, NMR analysis of the fates of proline, arginine,

histidine, and histidine in all five regulator mutants (CcpA, CodY, AhrC, ArgR1, and
ArgR2) when grown in CDM would provide useful information as to what catabolic
pathways these regulators function to activate or repress.

Moreover, amino acid

consumption analyses in these mutants could indicate if these regulators are involved in
the regulation of transport of these amino acids.

In conclusion, the findings of this

dissertation further characterize the metabolic and regulatory nodes involved in carbon
metabolism, which possibly contribute to in vivo survival and pathogenesis.
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Figure 5.4 Regulation of glutamate synthesis in the presence of a
preferred carbon source. In the presence of a preferred carbon source
such as glucose, CcpA functions to repress most genes involved in the
interconnected pathways of glutamate, arginine, and proline metabolism.
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Figure 5.5 Regulation of glutamate synthesis in the absence of a
preferred carbon source. In the absence of a preferred carbon source
such as glucose, CcpA alleviation (not including hut repression) allows for
expression of glutamate synthesis genes via amino acid catabolism. Hut
transcription is repressed in the absence of glucose by CcpA, CodY, and
AhrC activity, in CDM this repression is hypothesized to be functioning due
to the presence of proline and arginine. Transcription of putA is positively
regulated by ArgR1 and CodY. Northern blot data suggests CodY activation
is through derepression of an unknown activator, perhaps sensing proline
availability. Transcription of ArgG is repressed by CcpA, ArgR2, and AhrC
in the absence of glucose. In CDM, this repression is hypothesized to be
due to the presence of arginine during early exponential growth.
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Figure 5.6 Proposed model of S. aureus abscess survival. It is
proposed the staphylococcal abscess is carbon limited due to both
immune and bacterial cells utilizing glucose at the onset of infection.
Host factors such as iNOS and arginase (1A) utilize arginine for nitric
oxide production (iNOS) and collagen production (arginase). Bacterial
cells utilize arginine via ADI for ATP and ammonia production. Due to
the depletion of glucose, it is hypothesized that CcpA repression is
alleviated, allowing for utilization of amino acids such as proline as
carbon sources. The fibrin wall is cleaved by bacterial secreted
proteases such as ScpA, SspB, and aureolysin (2), as well as host
proteases such as MMP-9 (2), to liberate free proline or proline
containing peptides (3). The bacterial cells are then able to utilize these
free peptides and amino acids through specific transporters as carbon
sources for survival and persistence within the abscess (4).
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